KR102675413B1 - IbFAD8 gene from sweetpotato for improving cold storage stability and increasing omega-3 fatty acid content in tuberous root of sweetpotato and uses thereof - Google Patents
IbFAD8 gene from sweetpotato for improving cold storage stability and increasing omega-3 fatty acid content in tuberous root of sweetpotato and uses thereof Download PDFInfo
- Publication number
- KR102675413B1 KR102675413B1 KR1020210054406A KR20210054406A KR102675413B1 KR 102675413 B1 KR102675413 B1 KR 102675413B1 KR 1020210054406 A KR1020210054406 A KR 1020210054406A KR 20210054406 A KR20210054406 A KR 20210054406A KR 102675413 B1 KR102675413 B1 KR 102675413B1
- Authority
- KR
- South Korea
- Prior art keywords
- sweet potato
- ibfad8
- gene
- fatty acid
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000017020 Ipomoea batatas Species 0.000 title claims abstract description 116
- 235000002678 Ipomoea batatas Nutrition 0.000 title claims abstract description 86
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 85
- 238000003860 storage Methods 0.000 title claims abstract description 37
- 235000020660 omega-3 fatty acid Nutrition 0.000 title abstract description 30
- 229940012843 omega-3 fatty acid Drugs 0.000 title abstract description 29
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 title abstract description 24
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 23
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 21
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 21
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims abstract description 18
- 102000009114 Fatty acid desaturases Human genes 0.000 claims abstract description 12
- 108010087894 Fatty acid desaturases Proteins 0.000 claims abstract description 12
- 241000196324 Embryophyta Species 0.000 claims description 57
- 239000013598 vector Substances 0.000 claims description 32
- 102000004169 proteins and genes Human genes 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 20
- 230000009261 transgenic effect Effects 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 17
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 230000001131 transforming effect Effects 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 230000006353 environmental stress Effects 0.000 abstract description 7
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 39
- 230000014509 gene expression Effects 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 15
- 150000001413 amino acids Chemical group 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 150000004665 fatty acids Chemical class 0.000 description 12
- 230000035882 stress Effects 0.000 description 10
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 9
- 239000013604 expression vector Substances 0.000 description 9
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 8
- 235000020778 linoleic acid Nutrition 0.000 description 8
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 8
- 229940118019 malondialdehyde Drugs 0.000 description 8
- 238000011529 RT qPCR Methods 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 6
- 238000004817 gas chromatography Methods 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 5
- 239000006014 omega-3 oil Substances 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 229930002875 chlorophyll Natural products 0.000 description 4
- 235000019804 chlorophyll Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- 241000589158 Agrobacterium Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 3
- 229940090949 docosahexaenoic acid Drugs 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 210000001236 prokaryotic cell Anatomy 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- ZVEQWRWMRFIVSD-HRCADAONSA-N Pro-Phe-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N3CCC[C@@H]3C(=O)O ZVEQWRWMRFIVSD-HRCADAONSA-N 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000008645 cold stress Effects 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 230000011890 leaf development Effects 0.000 description 2
- 108010030617 leucyl-phenylalanyl-valine Proteins 0.000 description 2
- 125000005481 linolenic acid group Chemical group 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 108010090894 prolylleucine Proteins 0.000 description 2
- 230000021749 root development Effects 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- 101150044182 8 gene Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- BTBUEVAGZCKULD-XPUUQOCRSA-N Ala-Gly-His Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BTBUEVAGZCKULD-XPUUQOCRSA-N 0.000 description 1
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 1
- OKIKVSXTXVVFDV-MMWGEVLESA-N Ala-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N OKIKVSXTXVVFDV-MMWGEVLESA-N 0.000 description 1
- LNNSWWRRYJLGNI-NAKRPEOUSA-N Ala-Ile-Val Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O LNNSWWRRYJLGNI-NAKRPEOUSA-N 0.000 description 1
- ZXKNLCPUNZPFGY-LEWSCRJBSA-N Ala-Tyr-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N ZXKNLCPUNZPFGY-LEWSCRJBSA-N 0.000 description 1
- QAODJPUKWNNNRP-DCAQKATOSA-N Arg-Glu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QAODJPUKWNNNRP-DCAQKATOSA-N 0.000 description 1
- UFBURHXMKFQVLM-CIUDSAMLSA-N Arg-Glu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UFBURHXMKFQVLM-CIUDSAMLSA-N 0.000 description 1
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 1
- GXXWTNKNFFKTJB-NAKRPEOUSA-N Arg-Ile-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O GXXWTNKNFFKTJB-NAKRPEOUSA-N 0.000 description 1
- CLICCYPMVFGUOF-IHRRRGAJSA-N Arg-Lys-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O CLICCYPMVFGUOF-IHRRRGAJSA-N 0.000 description 1
- PRLPSDIHSRITSF-UNQGMJICSA-N Arg-Phe-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PRLPSDIHSRITSF-UNQGMJICSA-N 0.000 description 1
- JQHASVQBAKRJKD-GUBZILKMSA-N Arg-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N JQHASVQBAKRJKD-GUBZILKMSA-N 0.000 description 1
- SUMJNGAMIQSNGX-TUAOUCFPSA-N Arg-Val-Pro Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(O)=O SUMJNGAMIQSNGX-TUAOUCFPSA-N 0.000 description 1
- 200000000007 Arterial disease Diseases 0.000 description 1
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 1
- IICZCLFBILYRCU-WHFBIAKZSA-N Asn-Gly-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IICZCLFBILYRCU-WHFBIAKZSA-N 0.000 description 1
- VWADICJNCPFKJS-ZLUOBGJFSA-N Asn-Ser-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O VWADICJNCPFKJS-ZLUOBGJFSA-N 0.000 description 1
- NCXTYSVDWLAQGZ-ZKWXMUAHSA-N Asn-Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O NCXTYSVDWLAQGZ-ZKWXMUAHSA-N 0.000 description 1
- IPPFAOCLQSGHJV-WFBYXXMGSA-N Asn-Trp-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O IPPFAOCLQSGHJV-WFBYXXMGSA-N 0.000 description 1
- XOQYDFCQPWAMSA-KKHAAJSZSA-N Asn-Val-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XOQYDFCQPWAMSA-KKHAAJSZSA-N 0.000 description 1
- WQAOZCVOOYUWKG-LSJOCFKGSA-N Asn-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC(=O)N)N WQAOZCVOOYUWKG-LSJOCFKGSA-N 0.000 description 1
- ZLGKHJHFYSRUBH-FXQIFTODSA-N Asp-Arg-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLGKHJHFYSRUBH-FXQIFTODSA-N 0.000 description 1
- QQXOYLWJQUPXJU-WHFBIAKZSA-N Asp-Cys-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O QQXOYLWJQUPXJU-WHFBIAKZSA-N 0.000 description 1
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 1
- GBSUGIXJAAKZOW-GMOBBJLQSA-N Asp-Ile-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GBSUGIXJAAKZOW-GMOBBJLQSA-N 0.000 description 1
- SEMWSADZTMJELF-BYULHYEWSA-N Asp-Ile-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O SEMWSADZTMJELF-BYULHYEWSA-N 0.000 description 1
- AYFVRYXNDHBECD-YUMQZZPRSA-N Asp-Leu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AYFVRYXNDHBECD-YUMQZZPRSA-N 0.000 description 1
- SXLCDCZHNCLFGZ-BPUTZDHNSA-N Asp-Pro-Trp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O SXLCDCZHNCLFGZ-BPUTZDHNSA-N 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 101100512078 Caenorhabditis elegans lys-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000207782 Convolvulaceae Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- SPJRFUJMDJGDRO-UBHSHLNASA-N Cys-Trp-Ser Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CS)N)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 SPJRFUJMDJGDRO-UBHSHLNASA-N 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 241000702463 Geminiviridae Species 0.000 description 1
- JXFLPKSDLDEOQK-JHEQGTHGSA-N Gln-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O JXFLPKSDLDEOQK-JHEQGTHGSA-N 0.000 description 1
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 1
- FYBSCGZLICNOBA-XQXXSGGOSA-N Glu-Ala-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FYBSCGZLICNOBA-XQXXSGGOSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QSTLUOIOYLYLLF-WDSKDSINSA-N Gly-Asp-Glu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QSTLUOIOYLYLLF-WDSKDSINSA-N 0.000 description 1
- FZQLXNIMCPJVJE-YUMQZZPRSA-N Gly-Asp-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FZQLXNIMCPJVJE-YUMQZZPRSA-N 0.000 description 1
- TZOVVRJYUDETQG-RCOVLWMOSA-N Gly-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN TZOVVRJYUDETQG-RCOVLWMOSA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- VEPBEGNDJYANCF-QWRGUYRKSA-N Gly-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN VEPBEGNDJYANCF-QWRGUYRKSA-N 0.000 description 1
- MKIAPEZXQDILRR-YUMQZZPRSA-N Gly-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN MKIAPEZXQDILRR-YUMQZZPRSA-N 0.000 description 1
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 1
- DBUNZBWUWCIELX-JHEQGTHGSA-N Gly-Thr-Glu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DBUNZBWUWCIELX-JHEQGTHGSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- SOFSRBYHDINIRG-QTKMDUPCSA-N His-Arg-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CN=CN1)N)O SOFSRBYHDINIRG-QTKMDUPCSA-N 0.000 description 1
- SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 1
- VTMLJMNQHKBPON-QWRGUYRKSA-N His-Gly-His Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 VTMLJMNQHKBPON-QWRGUYRKSA-N 0.000 description 1
- FYTCLUIYTYFGPT-YUMQZZPRSA-N His-Gly-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FYTCLUIYTYFGPT-YUMQZZPRSA-N 0.000 description 1
- JSHOVJTVPXJFTE-HOCLYGCPSA-N His-Gly-Trp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O JSHOVJTVPXJFTE-HOCLYGCPSA-N 0.000 description 1
- IDQNVIWPPWAFSY-AVGNSLFASA-N His-His-Gln Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O IDQNVIWPPWAFSY-AVGNSLFASA-N 0.000 description 1
- JIUYRPFQJJRSJB-QWRGUYRKSA-N His-His-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)NCC(O)=O)C1=CN=CN1 JIUYRPFQJJRSJB-QWRGUYRKSA-N 0.000 description 1
- PMWSGVRIMIFXQH-KKUMJFAQSA-N His-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CN=CN1 PMWSGVRIMIFXQH-KKUMJFAQSA-N 0.000 description 1
- YAALVYQFVJNXIV-KKUMJFAQSA-N His-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 YAALVYQFVJNXIV-KKUMJFAQSA-N 0.000 description 1
- BCSGDNGNHKBRRJ-ULQDDVLXSA-N His-Tyr-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CN=CN2)N BCSGDNGNHKBRRJ-ULQDDVLXSA-N 0.000 description 1
- QLBXWYXMLHAREM-PYJNHQTQSA-N His-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CN=CN1)N QLBXWYXMLHAREM-PYJNHQTQSA-N 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 description 1
- TZCGZYWNIDZZMR-UHFFFAOYSA-N Ile-Arg-Ala Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(C)C(O)=O)CCCN=C(N)N TZCGZYWNIDZZMR-UHFFFAOYSA-N 0.000 description 1
- QYZYJFXHXYUZMZ-UGYAYLCHSA-N Ile-Asn-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N QYZYJFXHXYUZMZ-UGYAYLCHSA-N 0.000 description 1
- MQFGXJNSUJTXDT-QSFUFRPTSA-N Ile-Gly-Ile Chemical compound N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)O MQFGXJNSUJTXDT-QSFUFRPTSA-N 0.000 description 1
- AMSYMDIIIRJRKZ-HJPIBITLSA-N Ile-His-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N AMSYMDIIIRJRKZ-HJPIBITLSA-N 0.000 description 1
- LRAUKBMYHHNADU-DKIMLUQUSA-N Ile-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CC1=CC=CC=C1 LRAUKBMYHHNADU-DKIMLUQUSA-N 0.000 description 1
- XQLGNKLSPYCRMZ-HJWJTTGWSA-N Ile-Phe-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)O)N XQLGNKLSPYCRMZ-HJWJTTGWSA-N 0.000 description 1
- BJECXJHLUJXPJQ-PYJNHQTQSA-N Ile-Pro-His Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N BJECXJHLUJXPJQ-PYJNHQTQSA-N 0.000 description 1
- NSPNUMNLZNOPAQ-SJWGOKEGSA-N Ile-Tyr-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N NSPNUMNLZNOPAQ-SJWGOKEGSA-N 0.000 description 1
- SWNRZNLXMXRCJC-VKOGCVSHSA-N Ile-Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(O)=O)=CNC2=C1 SWNRZNLXMXRCJC-VKOGCVSHSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 1
- DUBAVOVZNZKEQQ-AVGNSLFASA-N Leu-Arg-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CCCN=C(N)N DUBAVOVZNZKEQQ-AVGNSLFASA-N 0.000 description 1
- DBVWMYGBVFCRBE-CIUDSAMLSA-N Leu-Asn-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DBVWMYGBVFCRBE-CIUDSAMLSA-N 0.000 description 1
- VBZOAGIPCULURB-QWRGUYRKSA-N Leu-Gly-His Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N VBZOAGIPCULURB-QWRGUYRKSA-N 0.000 description 1
- APFJUBGRZGMQFF-QWRGUYRKSA-N Leu-Gly-Lys Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN APFJUBGRZGMQFF-QWRGUYRKSA-N 0.000 description 1
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 1
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 1
- FYPWFNKQVVEELI-ULQDDVLXSA-N Leu-Phe-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 FYPWFNKQVVEELI-ULQDDVLXSA-N 0.000 description 1
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 1
- KWLWZYMNUZJKMZ-IHRRRGAJSA-N Leu-Pro-Leu Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O KWLWZYMNUZJKMZ-IHRRRGAJSA-N 0.000 description 1
- IWMJFLJQHIDZQW-KKUMJFAQSA-N Leu-Ser-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IWMJFLJQHIDZQW-KKUMJFAQSA-N 0.000 description 1
- GZRABTMNWJXFMH-UVOCVTCTSA-N Leu-Thr-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZRABTMNWJXFMH-UVOCVTCTSA-N 0.000 description 1
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 1
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- GKFNXYMAMKJSKD-NHCYSSNCSA-N Lys-Asp-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GKFNXYMAMKJSKD-NHCYSSNCSA-N 0.000 description 1
- GHOIOYHDDKXIDX-SZMVWBNQSA-N Lys-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN)C(O)=O)=CNC2=C1 GHOIOYHDDKXIDX-SZMVWBNQSA-N 0.000 description 1
- CAVGLNOOIFHJOF-SRVKXCTJSA-N Lys-His-Cys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCCN)N CAVGLNOOIFHJOF-SRVKXCTJSA-N 0.000 description 1
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 1
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 1
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 1
- AFLBTVGQCQLOFJ-AVGNSLFASA-N Lys-Pro-Arg Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O AFLBTVGQCQLOFJ-AVGNSLFASA-N 0.000 description 1
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 1
- DYJOORGDQIGZAS-DCAQKATOSA-N Lys-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N DYJOORGDQIGZAS-DCAQKATOSA-N 0.000 description 1
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 1
- ZWBCVBHKXHPCEI-BVSLBCMMSA-N Met-Phe-Trp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N ZWBCVBHKXHPCEI-BVSLBCMMSA-N 0.000 description 1
- OOXVBECOTYHTCK-WDSOQIARSA-N Met-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCSC)N OOXVBECOTYHTCK-WDSOQIARSA-N 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- MQVFHOPCKNTHGT-MELADBBJSA-N Phe-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O MQVFHOPCKNTHGT-MELADBBJSA-N 0.000 description 1
- APJPXSFJBMMOLW-KBPBESRZSA-N Phe-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 APJPXSFJBMMOLW-KBPBESRZSA-N 0.000 description 1
- KAJLHCWRWDSROH-BZSNNMDCSA-N Phe-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=CC=C1 KAJLHCWRWDSROH-BZSNNMDCSA-N 0.000 description 1
- CZQZSMJXFGGBHM-KKUMJFAQSA-N Phe-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O CZQZSMJXFGGBHM-KKUMJFAQSA-N 0.000 description 1
- YMIZSYUAZJSOFL-SRVKXCTJSA-N Phe-Ser-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O YMIZSYUAZJSOFL-SRVKXCTJSA-N 0.000 description 1
- VIIRRNQMMIHYHQ-XHSDSOJGSA-N Phe-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N VIIRRNQMMIHYHQ-XHSDSOJGSA-N 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- CPRLKHJUFAXVTD-ULQDDVLXSA-N Pro-Leu-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CPRLKHJUFAXVTD-ULQDDVLXSA-N 0.000 description 1
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 1
- DWGFLKQSGRUQTI-IHRRRGAJSA-N Pro-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1 DWGFLKQSGRUQTI-IHRRRGAJSA-N 0.000 description 1
- NAIPAPCKKRCMBL-JYJNAYRXSA-N Pro-Pro-Phe Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1NCCC1)C1=CC=CC=C1 NAIPAPCKKRCMBL-JYJNAYRXSA-N 0.000 description 1
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 1
- DLZBBDSPTJBOOD-BPNCWPANSA-N Pro-Tyr-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O DLZBBDSPTJBOOD-BPNCWPANSA-N 0.000 description 1
- JXVXYRZQIUPYSA-NHCYSSNCSA-N Pro-Val-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JXVXYRZQIUPYSA-NHCYSSNCSA-N 0.000 description 1
- 108010079005 RDV peptide Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 1
- MESDJCNHLZBMEP-ZLUOBGJFSA-N Ser-Asp-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MESDJCNHLZBMEP-ZLUOBGJFSA-N 0.000 description 1
- RNFKSBPHLTZHLU-WHFBIAKZSA-N Ser-Cys-Gly Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)O)N)O RNFKSBPHLTZHLU-WHFBIAKZSA-N 0.000 description 1
- MOVJSUIKUNCVMG-ZLUOBGJFSA-N Ser-Cys-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N)O MOVJSUIKUNCVMG-ZLUOBGJFSA-N 0.000 description 1
- GYXVUTAOICLGKJ-ACZMJKKPSA-N Ser-Glu-Cys Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N GYXVUTAOICLGKJ-ACZMJKKPSA-N 0.000 description 1
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 1
- QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 1
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 1
- YXEYTHXDRDAIOJ-CWRNSKLLSA-N Ser-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CO)N)C(=O)O YXEYTHXDRDAIOJ-CWRNSKLLSA-N 0.000 description 1
- PLQWGQUNUPMNOD-KKUMJFAQSA-N Ser-Tyr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PLQWGQUNUPMNOD-KKUMJFAQSA-N 0.000 description 1
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- JXKMXEBNZCKSDY-JIOCBJNQSA-N Thr-Asp-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O JXKMXEBNZCKSDY-JIOCBJNQSA-N 0.000 description 1
- UBDDORVPVLEECX-FJXKBIBVSA-N Thr-Gly-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O UBDDORVPVLEECX-FJXKBIBVSA-N 0.000 description 1
- IMYTYAWRKBYTSX-YTQUADARSA-N Trp-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)N)C(=O)O IMYTYAWRKBYTSX-YTQUADARSA-N 0.000 description 1
- CXPJPTFWKXNDKV-NUTKFTJISA-N Trp-Leu-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 CXPJPTFWKXNDKV-NUTKFTJISA-N 0.000 description 1
- ADMHZNPMMVKGJW-BPUTZDHNSA-N Trp-Ser-Arg Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N ADMHZNPMMVKGJW-BPUTZDHNSA-N 0.000 description 1
- NMOIRIIIUVELLY-WDSOQIARSA-N Trp-Val-Leu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)C(C)C)=CNC2=C1 NMOIRIIIUVELLY-WDSOQIARSA-N 0.000 description 1
- UOXPLPBMEPLZBW-WDSOQIARSA-N Trp-Val-Lys Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 UOXPLPBMEPLZBW-WDSOQIARSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- AKXBNSZMYAOGLS-STQMWFEESA-N Tyr-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AKXBNSZMYAOGLS-STQMWFEESA-N 0.000 description 1
- ULHJJQYGMWONTD-HKUYNNGSSA-N Tyr-Gly-Trp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ULHJJQYGMWONTD-HKUYNNGSSA-N 0.000 description 1
- CTDPLKMBVALCGN-JSGCOSHPSA-N Tyr-Gly-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O CTDPLKMBVALCGN-JSGCOSHPSA-N 0.000 description 1
- FBHBVXUBTYVCRU-BZSNNMDCSA-N Tyr-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CN=CN1 FBHBVXUBTYVCRU-BZSNNMDCSA-N 0.000 description 1
- YKCXQOBTISTQJD-BZSNNMDCSA-N Tyr-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N YKCXQOBTISTQJD-BZSNNMDCSA-N 0.000 description 1
- GPLTZEMVOCZVAV-UFYCRDLUSA-N Tyr-Tyr-Arg Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=C(O)C=C1 GPLTZEMVOCZVAV-UFYCRDLUSA-N 0.000 description 1
- DJSYPCWZPNHQQE-FHWLQOOXSA-N Tyr-Tyr-Gln Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(O)=O)C1=CC=C(O)C=C1 DJSYPCWZPNHQQE-FHWLQOOXSA-N 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 108010064997 VPY tripeptide Proteins 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- LTFLDDDGWOVIHY-NAKRPEOUSA-N Val-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N LTFLDDDGWOVIHY-NAKRPEOUSA-N 0.000 description 1
- NMANTMWGQZASQN-QXEWZRGKSA-N Val-Arg-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N NMANTMWGQZASQN-QXEWZRGKSA-N 0.000 description 1
- CVIXTAITYJQMPE-LAEOZQHASA-N Val-Glu-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CVIXTAITYJQMPE-LAEOZQHASA-N 0.000 description 1
- JVGHIFMSFBZDHH-WPRPVWTQSA-N Val-Met-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)O)N JVGHIFMSFBZDHH-WPRPVWTQSA-N 0.000 description 1
- QWCZXKIFPWPQHR-JYJNAYRXSA-N Val-Pro-Tyr Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QWCZXKIFPWPQHR-JYJNAYRXSA-N 0.000 description 1
- JXWGBRRVTRAZQA-ULQDDVLXSA-N Val-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N JXWGBRRVTRAZQA-ULQDDVLXSA-N 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- UDMBCSSLTHHNCD-DGPXGRDGSA-N [(2r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-DGPXGRDGSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000408 embryogenic effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000003208 gene overexpression Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 150000002410 histidine derivatives Chemical class 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- -1 pEMU Proteins 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 108010084572 phenylalanyl-valine Proteins 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000009417 vegetative reproduction Effects 0.000 description 1
- 238000013466 vegetative reproduction Methods 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/06—Processes for producing mutations, e.g. treatment with chemicals or with radiation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/12—Processes for modifying agronomic input traits, e.g. crop yield
- A01H1/122—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/06—Roots
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
본 발명은 고구마 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량을 증가시키는 고구마 유래 IbFAD8 (Ipomoea batatas Fatty acid desaturase 8) 유전자 및 이의 용도에 관한 것으로, IbFAD8 유전자를 이용하여 조건 불리지역에서의 환경 스트레스 내성 및 저온 저장능력 향상으로 고구마의 저장성 개선과 고혈압, 심혈관 질병에 효과적인 리놀렌산 고함량 고구마를 개발하는데 유용하게 활용될 수 있을 것이다.The present invention relates to the sweet potato-derived IbFAD8 ( Ipomoea batatas Fatty acid desaturase 8) gene, which increases the low-temperature storage capacity and omega-3 fatty acid content of sweet potato tubers, and its use. The IbFAD8 gene is used to reduce environmental stress in unfavorable areas. By improving tolerance and low-temperature storage ability, it can be usefully used to improve the storage properties of sweet potatoes and to develop sweet potatoes with high linolenic acid content, which are effective for high blood pressure and cardiovascular diseases.
Description
본 발명은 고구마 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량을 증가시키는 고구마 유래 IbFAD8 (Ipomoea batatas Fatty acid desaturase 8) 유전자 및 이의 용도에 관한 것이다.The present invention relates to the sweet potato-derived IbFAD8 ( Ipomoea batatas Fatty acid desaturase 8) gene, which increases the low-temperature storage capacity and omega-3 fatty acid content of sweet potato tubers, and its use.
오메가(ω)란 '마지막, 끝'을 뜻하는 단어로, 지방산 분자를 구성하는 탄소 사슬의 가장 끝 탄소로부터 세 번째에 위치한 탄소에서부터 이중결합이 형성된 불포화 지방산을 오메가-3 지방산이라 부른다.Omega (ω) is a word meaning 'last, end', and unsaturated fatty acids in which a double bond is formed from the third carbon from the end carbon of the carbon chain that makes up the fatty acid molecule are called omega-3 fatty acids.
알파-리놀렌산(alpha-linolenic acid, 오메가-3 지방산)은 체내에서는 합성되지 않는 필수지방산으로 식품으로 섭취해야 하며, 체내에서 EPA (eicosapentaenoic acid)와 DHA (docosahexaenoic acid)로 전환되는 전구물질(precursor)로, 혈중 콜레스테롤을 저하시켜 주고 혈관 염증 지표 물질들을 감소시켜 주어 심장 질환 예방에 효과적이라고 알려져 있다.Alpha-linolenic acid (omega-3 fatty acid) is an essential fatty acid that cannot be synthesized in the body and must be consumed through food. It is a precursor that is converted into EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in the body. It is known to be effective in preventing heart disease by lowering blood cholesterol and reducing vascular inflammation indicators.
오메가 3 지방산은 인체 안에서 세포를 보호하고, 세포구조를 유지시키며 원활한 신진대사를 돕는다. 또한 혈액의 피막형성을 억제하고, 뼈의 형성을 촉진 및 강화하는 효과가 있다. 오메가 3 지방산이 부족하면 두뇌와 망막에 필요한 DHA가 부족해 학습능력과 시각기능이 떨어지게 된다고 알려져 있다. 최근 연구된 결과에 의하면 알파-리놀렌산이 염증의 마커인 C-반응성 단백질을 감소시켰다는 임상연구결과가 보고되었으며, 알파-리놀렌산을 섭취하면 혈중 콜레스테롤이 저하되고 심혈관계 질환 발생 위험성을 감소시켜주며 동맥의 기능이 보호되는 효과 등을 얻을 수 있다.Omega-3 fatty acids protect cells in the human body, maintain cell structure, and help with smooth metabolism. It also has the effect of suppressing blood film formation and promoting and strengthening bone formation. It is known that a lack of omega-3 fatty acids leads to a lack of DHA required for the brain and retina, which reduces learning ability and visual function. According to recent research results, clinical research has reported that alpha-linolenic acid reduces C-reactive protein, a marker of inflammation. Consuming alpha-linolenic acid lowers blood cholesterol, reduces the risk of cardiovascular disease, and reduces arterial disease. You can achieve the effect of protecting functions, etc.
고구마(Ipomoea batatas)는 메꽃과의 여러해살이풀로, 줄기 밑쪽의 잎자루 기부에서 뿌리를 내는데 그 일부가 땅속에서 커져 덩이뿌리인 고구마가 된다. 고구마는 비교적 척박한 땅에도 재배가 가능할 뿐만 아니라 헥타르당 생산량이 약 30톤으로 식량과 가축사료로 이용되는 대표적인 뿌리작물이다. 덩이뿌리의 성분은 수분 69.39%, 당질 27.7%, 단백질 1.3% 등이며 주성분은 녹말이다. 제2차 세계대전 이전에는 대부분 식용으로 소비하였으나, 최근에는 식용이 40% 안팎에 그쳐 주로 부식 또는 간식으로 이용된다. 공업용으로는 녹말용으로 30% 정도 사용하고 엿, 포도당, 과자류, 식용가공품, 의약품, 화장품, 알코올, 위스키, 소주 등의 원료로 많이 사용된다. 돼지 등의 가축 사료용으로도 쓰이며 잎과 줄기는 땅의 생산력을 유지하는 풋거름으로 사용한다.Sweet potato ( Ipomoea batatas ) is a perennial plant of the Convolvulaceae family. It grows roots from the base of the petiole at the bottom of the stem, and a part of it grows underground to become a sweet potato, a tuberous root. Sweet potatoes are a representative root crop that can be grown even on relatively barren land and are used as food and livestock feed, with a production volume of about 30 tons per hectare. The components of the tuber include 69.39% moisture, 27.7% sugar, and 1.3% protein, and the main component is starch. Before World War II, most people consumed it for food, but recently, only about 40% of it is edible, and it is mainly used as side dishes or snacks. For industrial purposes, about 30% is used for starch, and it is widely used as a raw material for taffy, glucose, confectionery, processed edible products, medicine, cosmetics, alcohol, whiskey, and soju. It is also used as feed for livestock such as pigs, and the leaves and stems are used as green manure to maintain the productivity of the land.
한편, 한국공개특허 제2018-0073430호에는 'FAD2 유전자 조작된 올레인산 강화 식물체 및 이의 제조 방법'이 개시되어 있고, 한국등록특허 제2038481호에는 '레스퀘렐라 유래 PfFAD3-1 유전자로 형질전환된 수확량이 증가된 콩 식물체 및 이의 제조방법'이 개시되어 있으나, 본 발명의 '고구마 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량을 증가시키는 고구마 유래 IbFAD8 유전자 및 이의 용도'에 대해서는 기재된 바가 없다.Meanwhile, Korean Patent Publication No. 2018-0073430 discloses 'FAD2 genetically engineered oleic acid-enhanced plant and method of manufacturing same', and Korean Patent No. 2038481 discloses 'Yield transformed with PfFAD3-1 gene derived from Resquerella'. Although this 'enhanced soybean plant and method for producing the same' is disclosed, there is no description of the 'sweet potato-derived IbFAD8 gene that increases the low-temperature storage capacity and omega-3 fatty acid content of sweet potato tubers and its use' of the present invention.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 저온 저장성이 향상되고 오메가-3 지방산의 함량이 높은 고구마를 개발하기 위해, 오메가-6 지방산 리놀레산(C18:2)을 오메가-3 지방산 리놀렌산(C18:3)으로 불포화시켜 식물세포 내 지방산 조성을 변화시키는 기능의 FAD8 (Fatty acid desaturase 8) 유전자를 고구마(Ipomoea batatas)에서 분리하였고, 상기 IbFAD8 유전자를 과발현하는 형질전환 고구마를 제조하여 특성을 분석한 결과, IbFAD8 유전자 과발현 형질전환 고구마는 덩이뿌리에서 리놀렌산/리놀레산 비율이 증가하였고, 덩이뿌리의 저온 저장성이 향상되었으며, 형질전환 고구마 식물체의 저온 및 건조 스트레스 내성이 비형질전환 고구마 식물체에 비해 증가하였음을 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above needs. In order to develop sweet potatoes with improved low-temperature storage and high content of omega-3 fatty acids, the present inventors used the omega-6 fatty acid linoleic acid (C18:2) as an omega-3 fatty acid. The FAD8 (Fatty acid desaturase 8) gene, which has the function of changing the fatty acid composition in plant cells by desaturating it with linolenic acid (C18:3), was isolated from sweet potato ( Ipomoea batatas ), and a transgenic sweet potato overexpressing the IbFAD8 gene was prepared and characterized. As a result of the analysis, the linolenic acid/linoleic acid ratio of the transgenic sweet potato overexpressing the IbFAD8 gene was increased in the tubers, the low-temperature storage ability of the tubers was improved, and the low temperature and drying stress tolerance of the transgenic sweet potato plants was increased compared to the non-transgenic sweet potato plants. By confirming that this was done, the present invention was completed.
상기 과제를 해결하기 위해, 본 발명은 서열번호 2의 아미노산 서열로 이루어진 고구마 유래 IbFAD8 (Ipomoea batatas Fatty acid desaturase 8) 단백질을 코딩하는 유전자를 포함하는 재조합 벡터로 고구마 식물세포를 형질전환시켜 IbFAD8 유전자를 과발현시키는 단계를 포함하는 야생형에 비해 고구마 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량을 증가시키는 방법을 제공한다.In order to solve the above problem, the present invention transforms sweet potato plant cells with a recombinant vector containing a gene encoding the sweet potato-derived IbFAD8 ( Ipomoea batatas Fatty acid desaturase 8) protein consisting of the amino acid sequence of SEQ ID NO: 2, thereby generating the IbFAD8 gene. A method for increasing low-temperature storage and omega-3 fatty acid content of sweet potato tubers compared to the wild type, including the step of overexpressing, is provided.
또한, 본 발명은 서열번호 2의 아미노산 서열로 이루어진 고구마 유래 IbFAD8 단백질을 코딩하는 유전자를 포함하는 재조합 벡터로 고구마 식물세포를 형질전환시키는 단계; 및 상기 형질전환된 고구마 식물세포로부터 형질전환 고구마 식물체를 재분화하는 단계를 포함하는 야생형에 비해 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량이 증가된 형질전환 고구마 식물체의 제조방법을 제공한다.In addition, the present invention includes the steps of transforming sweet potato plant cells with a recombinant vector containing a gene encoding the sweet potato-derived IbFAD8 protein consisting of the amino acid sequence of SEQ ID NO: 2; and redifferentiating the transformed sweet potato plant from the transformed sweet potato plant cell. It provides a method for producing a transformed sweet potato plant with increased low-temperature storage capacity and omega-3 fatty acid content of the tuber compared to the wild type.
또한, 본 발명은 상기 방법에 의해 제조된 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량이 증가된 형질전환 고구마 식물체 및 이의 덩이뿌리를 제공한다.In addition, the present invention provides transgenic sweet potato plants and tubers thereof with increased low-temperature storage and omega-3 fatty acid content of the tubers prepared by the above method.
또한, 본 발명은 서열번호 2의 아미노산 서열로 이루어진 고구마 유래 IbFAD8 단백질을 코딩하는 유전자를 유효성분으로 함유하는, 고구마 덩이뿌리의 저온 저장성 및 오메가-3 지방산 함량 증진용 조성물을 제공한다.In addition, the present invention provides a composition for improving low-temperature storage and omega-3 fatty acid content of sweet potato tubers, which contains as an active ingredient a gene encoding the sweet potato-derived IbFAD8 protein consisting of the amino acid sequence of SEQ ID NO: 2.
본 발명에 따른 IbFAD8 (Ipomoea batatas Fatty acid desaturase 8) 유전자 과발현 형질전환 고구마는 덩이뿌리의 저온저장성이 향상되고, 덩이뿌리에서 리놀렌산이 야생형에 비해 현저히 증가하며, 저온 및 건조 스트레스 내성 또한 증가되는 것으로 확인되었다. 따라서 IbFAD8 유전자를 이용하여 조건 불리지역에서 고구마의 환경 스트레스 내성 및 저온 저장능력 향상 효과를 꾀할 수 있고, 고혈압, 심혈관 질병에 효과적인 리놀렌산 고함량 고구마를 개발하여 산업적으로 유용하게 활용할 수 있을 것이다.Transgenic sweet potatoes overexpressing the IbFAD8 ( Ipomoea batatas Fatty acid desaturase 8) gene according to the present invention were confirmed to have improved low-temperature storage of tubers, significantly increased linolenic acid in tubers compared to the wild type, and increased low-temperature and drying stress tolerance. It has been done. Therefore, by using the IbFAD8 gene, it is possible to improve the environmental stress tolerance and low-temperature storage ability of sweet potatoes in unfavorable areas, and develop sweet potatoes with high linoleic acid content that are effective against high blood pressure and cardiovascular diseases, which can be used industrially.
도 1(a)는 고구마 유래 IbFAD8 단백질의 아미노산 및 염기서열 분석 결과이고, (b) 및 (c)는 아미노산 서열을 근거로 다른 식물의 FAD와 유연관계를 비교한 결과이며, (d)는 IbFAD8 염기서열에 GFP을 결합시킨 벡터를 담배 잎에 접종하여 일시 발현시킨 후 공초점 현미경(confocal microscopy)으로 관찰한 결과이다.
도 2는 고구마 조직별 IbFAD8 유전자의 발현을 분석한 것으로, 잎(leaves, L), 줄기(stems, S), 실뿌리(fibrous roots, FR), 굳은뿌리(pencil roots, PR) 및 덩이뿌리(tuberous roots, TR)에서 IbFAD8 유전자의 발현을 qRT-PCR로 분석한 결과이다.
도 3은 고구마 잎에서 IbFAD8 유전자의 발현 및 지방산 수준을 분석한 결과이다. 각 숫자는 고구마 식물체의 신초(shoot)로부터 2번째, 4번째, ... 12번째 잎을 의미한다.
도 4는 환경 스트레스 조건에서의 IbFAD8 유전자 발현 변화를 분석한 결과로, (a)는 저온(4℃) 및 고온(42℃) 조건의 고구마 잎에서 IbFAD8 유전자의 발현 변화를 분석한 결과이고, (b)는 저온(4℃) 조건에서 저장중인 덩이뿌리에서 IbFAD8 유전자의 발현 변화를 분석한 결과이며, (c)는 건조 스트레스(30% PEG) 조건 처리 후 잎이 달린 엽병에서 IbFAD8 유전자의 발현 변화를 분석한 결과이다.
도 5는 IbFAD8 과발현 형질전환 고구마 제작을 위한 재조합 벡터의 모식도(a), 상기 재조합 벡터로 형질전환된 고구마 식물체의 형질전환 여부를 검정한 PCR 결과(b) 및 선발된 형질전환체의 잎에서 IbFAD8 유전자의 발현을 qRT-PCR을 이용하여 확인한 결과(c)이다.
도 6은 IbFAD8 과발현 형질전환 고구마의 환경 스트레스 내성 분석 결과로, (a)는 저온 스트레스에 대한 내성 평가 결과이고, (b)는 건조 스트레스에 대한 내성 평가 결과이다.
도 7은 고구마의 뿌리 수량 결과로, 5개월 생육한 비형질전환체(NT)와 IbFAD8 과발현 형질전환 고구마 식물체(TF)로부터 뿌리를 수확하고 굳은뿌리(pencil roots, PR)와 덩이뿌리(tuberous roots, TR)로 분류한 결과이다.
도 8은 IbFAD8 과발현 형질전환 고구마 덩이뿌리에서의 저온 저장성 변화 분석 결과로, (a)는 수확된 NT와 TF 고구마의 덩이뿌리를 6주간 적정 저장온도(13℃) 및 저온(4℃) 조건에서 저장한 후 상태를 관찰한 사진이며, (b)는 MDA (malondialdehyde) 함량 분석 결과이다.Figure 1(a) is the result of amino acid and base sequence analysis of the IbFAD8 protein derived from sweet potato, (b) and (c) are the results of comparing the relationship with FAD of other plants based on the amino acid sequence, and (d) is the result of IbFAD8 This is the result of temporary expression by inoculating tobacco leaves with a vector combining GFP to the base sequence and observation using a confocal microscope.
Figure 2 is an analysis of the expression of the IbFAD8 gene in each sweet potato tissue, including leaves (L), stems (S), fibrous roots (FR), pencil roots (PR), and tuberous roots. This is the result of analyzing the expression of the IbFAD8 gene in roots (TR) by qRT-PCR.
Figure 3 shows the results of analyzing the expression and fatty acid levels of the IbFAD8 gene in sweet potato leaves. Each number represents the 2nd, 4th, ... 12th leaf from the shoot of the sweet potato plant.
Figure 4 shows the results of analyzing changes in IbFAD8 gene expression under environmental stress conditions. (a) shows the results of analyzing changes in expression of the IbFAD8 gene in sweet potato leaves under low temperature (4°C) and high temperature (42°C) conditions, ( b) is the result of analyzing the expression change of the IbFAD8 gene in tubers stored at low temperature (4℃), and (c) is the expression change of the IbFAD8 gene in leaf petioles after treatment under dry stress (30% PEG) conditions. This is the result of analysis.
Figure 5 is a schematic diagram of a recombinant vector for producing a transgenic sweet potato overexpressing IbFAD8 (a), a PCR result testing the transformation of a sweet potato plant transformed with the recombinant vector (b), and IbFAD8 in the leaves of the selected transformant. This is the result (c) of confirming gene expression using qRT-PCR.
Figure 6 shows the results of environmental stress tolerance analysis of IbFAD8 -overexpressing transgenic sweet potatoes. (a) is the result of tolerance to cold stress, and (b) is the result of tolerance to drying stress.
Figure 7 shows the root yield results of sweet potato. Roots were harvested from non-transformant (NT) and IbFAD8- overexpressing transgenic sweet potato plants (TF) grown for 5 months, and pencil roots (PR) and tuberous roots were harvested. , TR).
Figure 8 shows the results of analysis of low-temperature storage changes in IbFAD8 -overexpressing transgenic sweet potato tubers. (a) shows harvested tubers of NT and TF sweet potatoes under appropriate storage temperature (13°C) and low temperature (4°C) conditions for 6 weeks. This is a photo observing the condition after storage, and (b) is the result of MDA (malondialdehyde) content analysis.
본 발명의 목적을 달성하기 위하여, 본 발명은 서열번호 2의 아미노산 서열로 이루어진 고구마 유래 IbFAD8 (Ipomoea batatas Fatty acid desaturase 8) 단백질을 코딩하는 유전자를 포함하는 재조합 벡터로 고구마 식물세포를 형질전환시켜 IbFAD8 유전자를 과발현시키는 단계를 포함하는, 야생형에 비해 고구마 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량을 증가시키는 방법을 제공한다.In order to achieve the object of the present invention, the present invention transforms sweet potato plant cells with a recombinant vector containing a gene encoding the sweet potato-derived IbFAD8 ( Ipomoea batatas Fatty acid desaturase 8) protein consisting of the amino acid sequence of SEQ ID NO: 2 to produce IbFAD8. A method for increasing low-temperature storage and omega-3 fatty acid content of sweet potato tubers compared to the wild type is provided, comprising the step of overexpressing the gene.
본 발명에서 덩이뿌리(tuberous root)란 식물의 뿌리가 양분을 저장하기위해 크고 뚱뚱해진 것으로, 괴근이라고도 한다. 뿌리의 변태형으로 방추형 또는 구형을 하고 있으며, 다수의 눈이 있어서 영양생식을 한다. 고구마, 순무, 쥐참외 등의 뿌리가 이에 해당되며, 다량의 녹말이나 당분을 저장하는 것이 보통이다.In the present invention, a tuberous root is a plant root that has become large and fat to store nutrients, and is also called a tuber. The root is spindle-shaped or spherical in shape and has multiple buds for vegetative reproduction. The roots of sweet potatoes, turnips, and melons fall into this category, and they usually store a large amount of starch or sugar.
본 발명에 따른 고구마 유래 IbFAD8 단백질의 범위는 서열번호 2로 표시되는 아미노산 서열을 갖는 단백질 및 상기 단백질의 기능적 동등물을 포함한다. "기능적 동등물"이란 아미노산의 부가, 치환 또는 결실의 결과, 상기 서열번호 2로 표시되는 아미노산 서열과 적어도 70% 이상, 바람직하게는 80% 이상, 더욱 바람직하게는 90% 이상, 더 더욱 바람직하게는 95% 이상의 서열 상동성을 갖는 것으로, 서열번호 2로 표시되는 단백질과 실질적으로 동질의 생리활성을 나타내는 단백질을 말한다. "실질적으로 동질의 생리활성"이란 고구마 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량을 증가시키는 활성을 의미한다.The scope of the IbFAD8 protein derived from sweet potato according to the present invention includes a protein having the amino acid sequence shown in SEQ ID NO: 2 and functional equivalents of the protein. “Functional equivalent” means at least 70% or more, preferably 80% or more, more preferably 90% or more, and even more preferably 90% or more, as a result of addition, substitution or deletion of amino acids, compared to the amino acid sequence shown in SEQ ID NO: 2. refers to a protein that has more than 95% sequence homology and exhibits substantially the same physiological activity as the protein represented by SEQ ID NO: 2. “Substantially the same physiological activity” refers to the activity of increasing the low-temperature storage capacity and omega-3 fatty acid content of sweet potato tubers.
또한, 본 발명은 IbFAD8 단백질을 코딩하는 유전자를 포함하며, 상기 유전자의 범위는 IbFAD8 단백질을 코딩하는 게놈 DNA, cDNA 및 합성 DNA를 모두 포함한다. 바람직하게는, 본 발명의 IbFAD8 단백질을 코딩하는 유전자는 서열번호 1로 표시되는 염기서열을 포함할 수 있다. 또한, 상기 염기 서열의 상동체가 본 발명의 범위 내에 포함된다. 구체적으로, 상기 유전자는 서열번호 1의 염기 서열과 각각 70% 이상, 더 바람직하게는 80% 이상, 더욱 바람직하게는 90% 이상, 가장 바람직하게는 95% 이상의 서열 상동성을 가지는 염기 서열을 포함할 수 있다. 폴리뉴클레오티드에 대한 "서열 상동성의 %"는 두 개의 최적으로 배열된 서열을 비교함으로써 확인되며, 비교 영역에서의 폴리뉴클레오티드 서열의 일부는 두 서열의 최적 배열에 대한 참고 서열(추가 또는 삭제를 포함하지 않음)에 비해 추가 또는 삭제(즉, 갭)를 포함할 수 있다.Additionally, the present invention includes a gene encoding the IbFAD8 protein, and the scope of the gene includes all of genomic DNA, cDNA, and synthetic DNA encoding the IbFAD8 protein. Preferably, the gene encoding the IbFAD8 protein of the present invention may include the base sequence represented by SEQ ID NO: 1. Additionally, homologs of the above base sequence are included within the scope of the present invention. Specifically, the gene includes a base sequence having sequence homology of at least 70%, more preferably at least 80%, even more preferably at least 90%, and most preferably at least 95% with the base sequence of SEQ ID NO: 1. can do. The “% sequence homology” for a polynucleotide is determined by comparing two optimally aligned sequences, wherein a portion of the polynucleotide sequence in the region of comparison is a reference sequence (not containing additions or deletions) for the optimal alignment of the two sequences. may contain additions or deletions (i.e. gaps) compared to
본 발명의 일 구현 예에 따른 저온 저장성 및 오메가-3 지방산의 함량 증가 방법에 있어서, 상기 오메가-3 지방산은 바람직하게는 리놀렌산(linolenic acid)일 수 있으나, 이에 제한되지 않는다.In the method for low-temperature storage and increasing the content of omega-3 fatty acids according to an embodiment of the present invention, the omega-3 fatty acid may preferably be linolenic acid, but is not limited thereto.
상기 "유전자 과발현"이란 야생형 식물에서 발현되는 수준 이상으로 상기 유전자가 발현되도록 하는 것을 의미한다. 식물체 내로 상기 유전자를 도입하는 방법으로는 프로모터의 조절을 받는 상기 유전자가 포함된 재조합 발현 벡터를 이용하여 식물체를 형질전환하는 방법이 있다.The term “gene overexpression” means causing the gene to be expressed above the level expressed in wild-type plants. A method of introducing the gene into a plant includes transforming the plant using a recombinant expression vector containing the gene under the control of a promoter.
용어 "재조합"은 세포가 이종의 핵산을 복제하거나, 상기 핵산을 발현하거나 또는 펩티드, 이종의 펩티드 또는 이종의 핵산에 의해 암호화된 단백질을 발현하는 세포를 지칭하는 것이다. 재조합 세포는 상기 세포의 천연 형태에서는 발견되지 않는 유전자 또는 유전자 절편을, 센스 또는 안티센스 형태 중 하나로 발현할 수 있다. 또한 재조합 세포는 천연 상태의 세포에서 발견되는 유전자를 발현할 수 있으며, 그러나 상기 유전자는 변형된 것으로서 인위적인 수단에 의해 세포 내 재도입된 것이다.The term “recombinant” refers to a cell that replicates a heterologous nucleic acid, expresses a heterologous nucleic acid, or expresses a peptide, heterologous peptide, or protein encoded by a heterologous nucleic acid. Recombinant cells can express genes or gene segments that are not found in the natural form of the cell, either in sense or antisense form. Additionally, recombinant cells can express genes found in cells in their natural state, but the genes have been modified and reintroduced into the cells by artificial means.
용어 "벡터"는 세포 내로 전달하는 DNA 단편(들), 핵산 분자를 지칭할 때 사용된다. 벡터는 DNA를 복제시키고, 숙주세포에서 독립적으로 재생산될 수 있다. 용어 "전달체"는 흔히 "벡터"와 호환하여 사용된다. 용어 "발현 벡터"는 목적한 코딩 서열과, 특정 숙주 생물에서 작동가능하게 연결된 코딩 서열을 발현하는데 필수적인 적정 핵산 서열을 포함하는 재조합 DNA 분자를 의미한다.The term “vector” is used to refer to a DNA fragment(s) or nucleic acid molecule that is delivered into a cell. Vectors replicate DNA and can reproduce independently in host cells. The term “vector” is often used interchangeably with “vector”. The term “expression vector” refers to a recombinant DNA molecule containing a coding sequence of interest and an appropriate nucleic acid sequence necessary to express the operably linked coding sequence in a particular host organism.
본 발명의 벡터는 전형적으로 클로닝 또는 발현을 위한 벡터로서 구축될 수 있다. 또한, 본 발명의 벡터는 원핵 세포 또는 진핵 세포를 숙주로 하여 구축될 수 있다. 예를 들어, 본 발명의 벡터가 발현 벡터이고, 원핵 세포를 숙주로 하는 경우에는, 전사를 진행시킬 수 있는 강력한 프로모터 (예컨대, pLλ프로모터, Trp 프로모터, Lac 프로모터, T7 프로모터, Tac 프로모터 등), 해독의 개시를 위한 리보좀 결합 자리 및 전사/해독 종결 서열을 포함하는 것이 일반적이다. 숙주 세포로서 대장균(Escherichia coli)이 이용되는 경우, E. coli 트립토판 생합성 경로의 프로모터 및 오퍼레이터 부위, 그리고 파아지 λ의 좌향 프로모터 (pLλ프로모터)가 조절 부위로서 이용될 수 있다.Vectors of the invention can typically be constructed as vectors for cloning or expression. Additionally, the vector of the present invention can be constructed using prokaryotic cells or eukaryotic cells as hosts. For example, when the vector of the present invention is an expression vector and a prokaryotic cell is used as a host, a strong promoter capable of advancing transcription (e.g., pLλ promoter, Trp promoter, Lac promoter, T7 promoter, Tac promoter, etc.), It typically includes a ribosome binding site for initiation of translation and a transcription/translation termination sequence. When Escherichia coli is used as a host cell, the promoter and operator regions of the E. coli tryptophan biosynthesis pathway and the left-handed promoter of phage λ (pLλ promoter) can be used as control regions.
한편, 본 발명에 이용될 수 있는 벡터는 당업계에서 종종 사용되는 플라스미드 (예: pSC101, ColE1, pBR322, pUC8/9, pHC79, pGEX 시리즈, pET 시리즈 및 pUC19 등), 파지 (예: λgt4·λB, λ-Charon, λΔz1 및 M13 등) 또는 바이러스 (예: SV40 등)를 조작하여 제작될 수 있다. 한편, 본 발명의 벡터가 발현 벡터이고, 진핵 세포를 숙주로 하는 경우에는, 포유동물 세포의 게놈으로부터 유래된 프로모터 (예: 메탈로티오닌 프로모터) 또는 포유동물 바이러스로부터 유래된 프로모터 (예: 아데노바이러스 후기 프로모터, 백시니아 바이러스 7.5K 프로모터, SV40 프로모터, 사이토메갈로바이러스 프로모터 및 HSV의 tk 프로모터)가 이용될 수 있으며, 전사 종결 서열로서 폴리아데닐화 서열을 일반적으로 갖는다.Meanwhile, vectors that can be used in the present invention include plasmids often used in the art (e.g., pSC101, ColE1, pBR322, pUC8/9, pHC79, pGEX series, pET series, and pUC19, etc.), phages (e.g., λgt4·λB) , λ-Charon, λΔz1, and M13, etc.) or viruses (e.g., SV40, etc.). On the other hand, when the vector of the present invention is an expression vector and uses a eukaryotic cell as a host, a promoter derived from the genome of a mammalian cell (e.g., metallothionein promoter) or a promoter derived from a mammalian virus (e.g., adenovirus) Viral late promoters, vaccinia virus 7.5K promoter, SV40 promoter, cytomegalovirus promoter and tk promoter of HSV) can be used and typically have a polyadenylation sequence as the transcription termination sequence.
본 발명의 재조합 벡터는 바람직하게는 식물 발현 벡터이다.The recombinant vector of the present invention is preferably a plant expression vector.
식물 발현 벡터의 바람직한 예는 아그로박테리움 튜머파시엔스 (Agrobacterium tumefaciens)와 같은 적당한 숙주에 존재할 때 그 자체의 일부, 소위 T-영역을 식물세포로 전이시킬 수 있는 Ti-플라스미드 벡터이다. 다른 유형의 Ti-플라스미드 벡터 (EP 0 116 718 B1호 참조)는 현재 식물세포, 또는 잡종 DNA를 식물의 게놈 내에 적당하게 삽입시키는 새로운 식물이 생산될 수 있는 원형질체로 잡종 DNA 서열을 전이시키는데 이용되고 있다. Ti플라스미드 벡터의 특히 바람직한 형태는 EP 0 120 516 B1호 및 미국 특허 제4,940,838호에 청구된 바와 같은 소위 바이너리(binary) 벡터이다. 본 발명에 따른 유전자를 식물 숙주에 도입시키는데 이용될 수 있는 다른 적합한 벡터는 이중 가닥 식물 바이러스 (예를 들면, CaMV) 및 단일 가닥 바이러스, 게미니 바이러스 등으로부터 유래될 수 있는 것과 같은 바이러스 벡터, 예를 들면 비완전성 식물 바이러스 벡터로부터 선택될 수 있다. 그러한 벡터의 사용은 특히 식물 숙주를 적당하게 형질전환 하는 것이 어려울 때 유리할 수 있다.A preferred example of a plant expression vector is the Ti-plasmid vector, which is capable of transferring part of itself, the so-called T-region, into plant cells when present in a suitable host such as Agrobacterium tumefaciens . Other types of Ti-plasmid vectors (see EP 0 116 718 B1) are currently used to transfer hybrid DNA sequences into plant cells or protoplasts from which new plants can be produced by appropriately inserting the hybrid DNA into the plant's genome. there is. A particularly preferred form of Tiplasmid vectors are the so-called binary vectors as claimed in EP 0 120 516 B1 and US Pat. No. 4,940,838. Other suitable vectors that can be used to introduce the genes according to the invention into a plant host include viral vectors such as those that may be derived from double-stranded plant viruses (e.g., CaMV) and single-stranded viruses, geminiviruses, etc. For example, it may be selected from non-intact plant virus vectors. The use of such vectors can be particularly advantageous when it is difficult to properly transform plant hosts.
발현 벡터는 바람직하게는 하나 이상의 선택성 마커를 포함한다. 상기 마커는 통상적으로 화학적인 방법으로 선택될 수 있는 특성을 갖는 핵산 서열로, 형질전환된 세포를 비형질전환 세포로부터 구별할 수 있는 모든 유전자가 이에 해당된다. 그 예로는 글리포세이트(glyphosate) 또는 포스피노트리신(포스피노트리신)과 같은 제초제 저항성 유전자, 카나마이신, G418, 블레오마이신(Bleomycin), 하이그로마이신(hygromycin), 클로람페니콜(chloramphenicol)과 같은 항생제 내성 유전자가 있으나, 이에 한정되는 것은 아니다.The expression vector preferably contains one or more selectable markers. The marker is a nucleic acid sequence that has characteristics that can be generally selected by chemical methods, and includes all genes that can distinguish transformed cells from non-transformed cells. Examples include herbicide resistance genes such as glyphosate or phosphinothricin, antibiotics such as kanamycin, G418, bleomycin, hygromycin, and chloramphenicol. There is a resistance gene, but it is not limited to this.
본 발명에 따른 식물 발현 벡터에서, 프로모터는 CaMV 35S, 액틴, 유비퀴틴, pEMU, MAS 또는 히스톤 프로모터일 수 있으나, 이에 제한되지 않는다. "프로모터"란 용어는 구조 유전자로부터의 DNA 업스트림의 영역을 의미하며 전사를 개시하기 위하여 RNA 폴리머라아제가 결합하는 DNA 분자를 말한다. "식물 프로모터"는 식물세포에서 전사를 개시할 수 있는 프로모터이다. "구성적(constitutive) 프로모터"는 대부분의 환경 조건 및 발달 상태 또는 세포 분화하에서 활성이 있는 프로모터이다. 형질전환체의 선택이 각종 단계에서 각종 조직에 의해서 이루어질 수 있기 때문에 구성적 프로모터가 본 발명에서 바람직할 수 있다. 따라서, 구성적 프로모터는 선택 가능성을 제한하지 않는다.In the plant expression vector according to the present invention, the promoter may be, but is not limited to, CaMV 35S, actin, ubiquitin, pEMU, MAS or histone promoter. The term "promoter" refers to the region of DNA upstream from a structural gene and refers to the DNA molecule to which RNA polymerase binds to initiate transcription. A “plant promoter” is a promoter capable of initiating transcription in plant cells. A “constitutive promoter” is a promoter that is active under most environmental conditions and developmental states or cell differentiation. Constitutive promoters may be preferred in the present invention because selection of transformants can be accomplished at various stages and by various tissues. Therefore, constitutive promoters do not limit selection possibilities.
본 발명에 따른 식물 발현 벡터에서, 터미네이터는 통상의 터미네이터를 사용할 수 있으며, 그 예로는 노팔린합성효소(nopaline synthase, NOS), 벼 α-아밀라아제 RAmy1 A 터미네이터, 파세올린(phaseoline) 터미네이터, 아그로박테리움 튜머파시엔스의 옥토파인(Octopine) 유전자의 터미네이터 등이 있으나, 이에 한정되는 것은 아니다. 터미네이터의 필요성에 관하여, 그러한 영역이 식물 세포에서의 전사의 확실성 및 효율을 증가시키는 것으로 일반적으로 알려져 있다. 그러므로, 터미네이터의 사용은 본 발명의 내용에서 매우 바람직하다.In the plant expression vector according to the present invention, the terminator can be a conventional terminator, examples of which include nopaline synthase (NOS), rice α-amylase RAmy1 A terminator, phaseoline terminator, and Agrobacterium terminator. These include, but are not limited to, the terminator of the Octopine gene of Rhium tumefaciens. Regarding the necessity of terminators, it is generally known that such regions increase the certainty and efficiency of transcription in plant cells. Therefore, the use of terminators is highly preferred in the context of the present invention.
식물의 형질전환에 이용되는 "식물 세포"는 어떤 식물 세포도 된다. 식물 세포는 배양 세포, 배양 조직, 배양 기관 또는 전체 식물, 바람직하게는 배양세포, 배양 조직 또는 배양 기관 및 더욱 바람직하게는 배양 세포의 어떤 형태도 된다. 용어 "식물 조직"은 분화된 또는 미분화된 식물의 조직, 예를 들면 이에 한정되진 않으나, 뿌리, 줄기, 잎, 꽃가루, 종자, 암 조직 및 배양에 이용되는 다양한 형태의 세포들, 즉 단일 세포, 원형질체(protoplast), 싹 및 캘러스 조직을 포함한다. 식물 조직은 인 플란타(in planta)이거나 기관 배양, 조직 배양 또는 세포 배양 상태일 수 있다.The “plant cell” used for plant transformation can be any plant cell. The plant cell may be any type of cultured cell, cultured tissue, cultured organ or whole plant, preferably cultured cell, cultured tissue or cultured organ and more preferably cultured cell. The term “plant tissue” refers to tissues of differentiated or undifferentiated plants, such as, but not limited to, roots, stems, leaves, pollen, seeds, cancer tissues, and various types of cells used in culture, i.e., single cells, Includes protoplast, bud and callus tissue. Plant tissue may be in planta or in organ culture, tissue culture, or cell culture.
본 발명의 벡터를 숙주세포 내로 운반하는 방법은, 숙주 세포가 원핵 세포인 경우, CaCl2 방법, 하나한 방법(Hanahan, D., (1983) J. Mol. Biol., 166:557-580) 및 전기천공법 등에 의해 실시될 수 있다. 또한, 숙주세포가 진핵세포인 경우에는, 미세주입법, 칼슘포스페이트 침전법, 전기천공법, 리포좀-매개 형질감염법, DEAE-덱스트란 처리법 및 유전자 밤바드먼트 등에 의해 벡터를 숙주세포 내로 주입할 수 있다.Methods for transporting the vector of the present invention into a host cell include, when the host cell is a prokaryotic cell, the CaCl 2 method or the Hanahan method (Hanahan, D., (1983) J. Mol. Biol., 166:557-580) and electroporation. In addition, when the host cell is a eukaryotic cell, the vector can be injected into the host cell by microinjection, calcium phosphate precipitation, electroporation, liposome-mediated transfection, DEAE-dextran treatment, and gene bombardment. there is.
본 발명은 또한,The present invention also,
서열번호 2의 아미노산 서열로 이루어진 고구마 유래 IbFAD8 (Ipomoea batatas Fatty acid desaturase 8) 단백질을 코딩하는 유전자를 포함하는 재조합 벡터로 고구마 식물세포를 형질전환시키는 단계; 및Transforming sweet potato plant cells with a recombinant vector containing a gene encoding the sweet potato IbFAD8 ( Ipomoea batatas Fatty acid desaturase 8) protein consisting of the amino acid sequence of SEQ ID NO: 2; and
상기 형질전환된 고구마 식물세포로부터 형질전환 고구마 식물체를 재분화하는 단계를 포함하는 야생형에 비해 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량이 증가된 형질전환 고구마 식물체의 제조방법을 제공한다.Provided is a method for producing transgenic sweet potato plants with increased low-temperature storage properties and omega-3 fatty acid content of the tubers compared to the wild type, including the step of redifferentiating the transformed sweet potato plants from the transformed sweet potato plant cells.
식물의 형질전환은 DNA를 식물에 전이시키는 임의의 방법을 의미한다. 그러한 형질전환 방법은 반드시 재생 및 (또는) 조직 배양 기간을 가질 필요는 없다. 식물 종의 형질전환은 이제는 쌍자엽 식물뿐만 아니라 단자엽 식물 양자를 포함한 식물 종에 대해 일반적이다. 원칙적으로, 임의의 형질전환 방법은 본 발명에 따른 잡종 DNA를 적당한 선조 세포로 도입시키는데 이용될 수 있다. 방법은 원형질체에 대한 칼슘/폴리에틸렌 글리콜 방법, 원형질체의 전기천공법, 식물 요소로의 현미주사법, 각종 식물 요소의 (DNA 또는 RNA-코팅된) 입자 충격법, 식물의 침윤 또는 성숙 화분 또는 소포자의 형질전환에 의한 아그로박테리움 투머파시엔스 매개된 유전자 전이에서 (비완전성) 바이러스에 의한 감염 등으로부터 적당하게 선택될 수 있다. 본 발명에 따른 바람직한 방법은 아그로박테리움 매개된 DNA 전달을 포함한다. 특히 바람직한 것은 EP A 120 516호 및 미국 특허 제4,940,838호에 기재된 바와 같은 소위 이원 벡터 기술을 이용하는 것이다.Plant transformation refers to any method of transferring DNA to a plant. Such transformation methods do not necessarily require a regeneration and/or tissue culture period. Transformation of plant species is now common for plant species including both monocots as well as dicots. In principle, any transformation method can be used to introduce the hybrid DNA according to the invention into suitable progenitor cells. Methods include the calcium/polyethylene glycol method for protoplasts, electroporation of protoplasts, microinjection into plant elements, particle bombardment (DNA or RNA-coated) of various plant elements, invasion of plants or characterization of mature pollen or spores. It can be appropriately selected from Agrobacterium tumefaciens-mediated gene transfer by conversion, infection by (non-complete) virus, etc. A preferred method according to the invention involves Agrobacterium mediated DNA transfer. Particular preference is given to using the so-called binary vector technology as described in EP A 120 516 and US Pat. No. 4,940,838.
본 발명의 제조방법은 본 발명에 따른 재조합 벡터로 식물세포를 형질전환하는 단계를 포함하는데, 상기 형질전환은 아그로박테리움 튜머파시엔스(A. tumefiaciens)에 의해 매개될 수 있다. 또한, 본 발명의 방법은 상기 형질전환된 식물세포로부터 형질전환 식물을 재분화하는 단계를 포함한다. 형질전환 식물세포로부터 형질전환 식물을 재분화하는 방법은 당업계에 공지된 임의의 방법을 이용할 수 있다.The production method of the present invention includes the step of transforming plant cells with the recombinant vector according to the present invention, and the transformation may be mediated by Agrobacterium tumefaciens ( A. tumefaciens ). Additionally, the method of the present invention includes the step of redifferentiating a transformed plant from the transformed plant cell. Any method known in the art can be used to redifferentiate a transgenic plant from a transgenic plant cell.
본 발명의 일 구현 예에 따른 제조방법에 있어서, 상기 형질전환된 식물세포에서 고구마 유래 IbFAD8 단백질 코딩 유전자의 발현을 증가시키면 야생형에 비해 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량이 증가된 형질전환 고구마 식물체를 제조할 수 있다. 상기 오메가-3 지방산은 바람직하게는 리놀렌산일 수 있으나, 이에 제한되지 않는다.In the production method according to one embodiment of the present invention, increasing the expression of the sweet potato-derived IbFAD8 protein coding gene in the transformed plant cells results in increased low-temperature storage of the tuber and increased omega-3 fatty acid content compared to the wild type. Converted sweet potato plants can be produced. The omega-3 fatty acid may preferably be linolenic acid, but is not limited thereto.
본 발명은 또한, 상기 방법에 의해 제조된 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량이 증가된 형질전환 고구마 식물체 및 이의 덩이뿌리를 제공한다.The present invention also provides transgenic sweet potato plants and tubers thereof with increased low-temperature storage and omega-3 fatty acid content of the tubers prepared by the above method.
전술한 것과 같이, 본 발명에 따른 형질전환 고구마 식물체는 야생형에 비해 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량이 증가된 것으로, 특히, IbFAD8 유전자의 과발현에 따른 오메가-3 지방산의 함량 증가가 잎보다 덩이뿌리에서 현저하게 증가되는 것이 특징이다. 상기 오메가-3 지방산은 바람직하게는 리놀렌산일 수 있으나, 이에 제한되지 않는다.As described above, the transgenic sweet potato plant according to the present invention has increased low-temperature storage and omega-3 fatty acid content of the tubers compared to the wild type. In particular, the content of omega-3 fatty acid increased due to overexpression of the IbFAD8 gene. It is characterized by a marked increase in tubers rather than leaves. The omega-3 fatty acid may preferably be linolenic acid, but is not limited thereto.
또한, 본 발명에 따른 덩이뿌리의 저온 저장성 및 오메가-3 지방산의 함량이 증가된 형질전환 고구마 식물체는 야생형에 비해 저온 및 건조 스트레스에 대한 내성도 증가된 것이 특징이다.In addition, the transgenic sweet potato plant with increased low-temperature storage capacity and omega-3 fatty acid content of the tubers according to the present invention is characterized by increased tolerance to low temperature and drying stress compared to the wild type.
본 발명은 또한, 서열번호 2의 아미노산 서열로 이루어진 고구마 유래 IbFAD8 (Ipomoea batatas Fatty acid desaturase 8) 단백질을 코딩하는 유전자를 유효성분으로 함유하는, 고구마 덩이뿌리의 저온 저장성 및 오메가-3 지방산 함량 증진용 조성물을 제공한다.The present invention also provides a method for improving low-temperature storage and omega-3 fatty acid content of sweet potato tubers, which contains as an active ingredient a gene encoding the sweet potato-derived IbFAD8 ( Ipomoea batatas Fatty acid desaturase 8) protein consisting of the amino acid sequence of SEQ ID NO: 2. A composition is provided.
본 발명의 조성물은 유효성분으로 서열번호 2의 아미노산 서열로 이루어진 고구마 유래 IbFAD8 단백질; 또는 이의 코딩 유전자를 함유하며, 상기 유전자 또는 상기 유전자를 포함하는 재조합 벡터로 식물 세포를 형질전환시킴으로써, 고구마 덩이뿌리의 저온 저장성 및 오메가-3 지방산 함량을 증가시킬 수 있는 것이다.The composition of the present invention contains, as an active ingredient, IbFAD8 protein derived from sweet potato consisting of the amino acid sequence of SEQ ID NO: 2; Alternatively, the low-temperature storability and omega-3 fatty acid content of sweet potato tubers can be increased by transforming plant cells with the gene or a recombinant vector containing the gene.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples only illustrate the present invention, and the content of the present invention is not limited to the following examples.
실시예 1. 고구마 유래 Example 1. Sweet potato origin Fatty acid desaturase 8Fatty acid desaturase 8 유전자 ( gene ( IbFAD8IbFAD8 ) 클로닝 및 서열 분석) Cloning and sequence analysis
고구마(Ipomoea batatas cv. Xushu 29) 식물체의 잎에서 Trizol (Invitrogen)을 이용하여 추출한 RNA로부터 TOPscript™ cDNA Synthesis kit (Enzynomics, 한국)를 사용하여 cDNA를 합성하였다. 이후, IbFAD8에 특이적인 정방향 프라이머(5'-ATGGCGAGTTGGGTGTTATC-3', 서열번호 3)와 역방향 프라이머(5'-TCACTTCTCGGTTCCAGCAA-3', 서열번호 4)를 이용하여 PCR을 수행하고, 전기영동하여 확보된 PCR 산물을 정제하는 방법으로 IbFAD8 유전자를 분리하였다.cDNA was synthesized from RNA extracted from the leaves of sweet potato ( Ipomoea batatas cv. Xushu 29) plants using Trizol (Invitrogen) using the TOPscript™ cDNA Synthesis kit (Enzynomics, Korea). Afterwards, PCR was performed using a forward primer (5'-ATGGCGAGTTGGGTGTTATC-3', SEQ ID NO: 3) and a reverse primer (5'-TCACTTCTCGGTTCCAGCAA-3', SEQ ID NO: 4) specific for IbFAD8 , and the obtained product was electrophoresed. The IbFAD8 gene was isolated by purifying the PCR product.
분리한 유전자의 시퀀싱 분석을 통해 서열을 분석한 결과 IbFAD8 유전자는 1,338개의 염기로 구성되어 있음을 확인하였고(도 1a), 아미노산 서열을 유추할 수 있었다. 상기 아미노산 서열을 근거로 다른 식물의 FAD 단백질(AtFAD8, OsFAD8, AtFAD7, OsFAD7)과의 유연관계를 비교한 결과, FAD 단백질에 특이적인 3개의 히스티딘 클러스터(HDCGH, HGWRISHRTHH, HHDIGTHVIHH)를 확인할 수 있었다(도 1b 및 c).As a result of analyzing the sequence of the isolated gene through sequencing analysis, it was confirmed that the IbFAD8 gene consists of 1,338 bases (Figure 1a), and the amino acid sequence could be inferred. As a result of comparing the relationship with FAD proteins (AtFAD8, OsFAD8, AtFAD7, OsFAD7) of other plants based on the above amino acid sequence, three histidine clusters (HDCGH, HGWRISHRTHH, HHDIGTHVIHH) specific to FAD protein were identified ( Figure 1b and c).
또한, IbFAD8 단백질 코딩 서열에 GFP 코딩 서열을 결합시킨 벡터를 담배 잎에 접종하여 일시 발현시킨 후 공초점 현미경(confocal microscopy)으로 관찰한 결과, IbFAD8 단백질은 엽록소 a를 둘러싸는 형태로 나타나 엽록체 막에 위치함을 알 수 있었다(도 1d).In addition, a vector combining the GFP coding sequence with the IbFAD8 protein coding sequence was inoculated into tobacco leaves and transiently expressed. As a result of observation using confocal microscopy, the IbFAD8 protein appeared in a form surrounding chlorophyll a and was located in the chloroplast membrane. The location could be seen (Figure 1d).
실시예 2. 고구마 조직별 Example 2. Sweet potato tissue type IbFAD8 IbFAD8 유전자 발현 수준 및 지방산 분석Gene expression levels and fatty acid analysis
고구마의 잎, 줄기, 실뿌리, 굳은뿌리 및 덩이뿌리에서 IbFAD8 발현 수준을 qRT-PCR을 활용하여 분석하였다. qRT-PCR은 96-웰 플레이트를 이용하여 CFX real-time PCR system (Bio-Rad™)으로 수행하였다. 각 반응물(최종 20 ㎕)은 2 ㎕의 희석된 cDNA와 10 ㎕의 EvaGreen PCR Master Mix (Biofact), 및 정방향 프라이머(5'-CCCCCATTTAAGCTGTCTGA-3', 서열번호 5), 역방향 프라이머(5'-ACATGGTTCCTTGAGCCAAC-3', 서열번호 6) 각 1 ㎕를 혼합하여 수행하였다. 그 결과, IbFAD8 유전자는 고구마 조직 중 잎(L)과 줄기(S)에서 발현이 상대적으로 높게 나타났다(도 2).The expression level of IbFAD8 in leaves, stems, thread roots, hard roots, and tubers of sweet potato was analyzed using qRT-PCR. qRT-PCR was performed with the CFX real-time PCR system (Bio-Rad™) using a 96-well plate. Each reaction (final 20 μl) contained 2 μl of diluted cDNA, 10 μl of EvaGreen PCR Master Mix (Biofact), and forward primer (5'-CCCCCATTTAAGCTGTCTGA-3', SEQ ID NO: 5) and reverse primer (5'-ACATGGTTCCTTGAGCCAAC). -3', SEQ ID NO: 6) was performed by mixing 1 ㎕ of each. As a result, the IbFAD8 gene showed relatively high expression in leaves (L) and stems (S) of sweet potato tissues (Figure 2).
또한, 고구마 잎 발달에 따른 IbFAD8 발현 변화를 분석한 결과, IbFAD8은 어리고 성숙한 잎에서 발현이 높으며, 노화된 잎에서는 발현이 감소하는 것으로 확인되었다(도 3a 및 b). 지방산 분석은 불꽃 이온화 검출기(flame ionization detector)가 장착된 Agilent series 7890A (Agilent Technologies Inc.)를 활용하여 GC (gas chromatography) 분석으로 수행하였다. 클로로포름: 헥산: 메탄올의 혼합시약(Chloroform: hexane: methanol, 8:5:2, v/v/v)을 이용하여, 동결건조된 고구마 샘플로부터 추출물을 확보하였다. 이후 메틸화(methylation) 시약 (0.25 M methanolic sodium methoxide: petroleum ether: ethyl ether, 1:5:2, v/v/v)과 혼합하여, DB-FFAP capillary column (30 m x 0.25 mm, 0.25 μm, Agilent Technologies Inc.)으로 지방산을 분리하였다. 잎 발달에 따른 지방산 조성(%) 분석 결과, 어린 잎과 노화된 잎에서는 리놀렌산(18:3) 지방산, 성숙한 잎에서는 리놀레산(18:2)의 조성이 가장 높게 나타났다(도 3c). In addition, as a result of analyzing changes in IbFAD8 expression according to sweet potato leaf development, it was confirmed that IbFAD8 expression was high in young and mature leaves, and expression was decreased in aged leaves (Figures 3a and b). Fatty acid analysis was performed by gas chromatography (GC) analysis using an Agilent series 7890A (Agilent Technologies Inc.) equipped with a flame ionization detector. Extracts were obtained from freeze-dried sweet potato samples using a mixture of chloroform: hexane: methanol (8:5:2, v/v/v). After mixing with methylation reagent (0.25 M methanolic sodium methoxide: petroleum ether: ethyl ether, 1:5:2, v/v/v), DB-FFAP capillary column (30 mx 0.25 mm, 0.25 μm, Agilent) Technologies Inc.), fatty acids were separated. As a result of analysis of fatty acid composition (%) according to leaf development, linolenic acid (18:3) fatty acid was found to be the highest in young and aged leaves, and linoleic acid (18:2) was found to be the highest in mature leaves (Figure 3c).
실시예 3. 환경 스트레스 조건하에서 Example 3. Under environmental stress conditions IbFAD8IbFAD8 유전자 발현 변화 분석 Gene expression change analysis
환경 스트레스에 의한 IbFAD8 발현 변화를 분석하기 위해, 25±2℃ 조건에서 4주간 생육시킨 고구마 식물체를 저온(4℃) 및 고온(42℃)에 0, 1, 3, 6, 12, 24 및 48시간 놓아둔 후 잎 조직을 이용하여 qRT-PCR을 수행하였다. 그 결과, IbFAD8은 저온 처리에 의해 발현이 급격하게 유도된 후 6시간 이후 감소되는 경향으로 확인되었으며, 고온 조건에서는 발현이 발현이 급격히 감소되는 것으로 나타났다(도 4a). 또한 저온(4℃)의 조건에서 저장중인 덩이뿌리에서 IbFAD8의 발현을 분석한 결과 저온저장 6주 후 IbFAD8의 발현이 증가하는 것으로 확인되었다(도 4b).To analyze changes in IbFAD8 expression due to environmental stress, sweet potato plants grown for 4 weeks at 25 ± 2℃ were grown at low (4℃) and high (42℃) temperatures at 0, 1, 3, 6, 12, 24, and 48. After letting it stand for some time, qRT-PCR was performed using leaf tissue. As a result, it was confirmed that the expression of IbFAD8 tended to decrease after 6 hours after being rapidly induced by low-temperature treatment, and that the expression was rapidly decreased under high-temperature conditions (Figure 4a). Additionally, as a result of analyzing the expression of IbFAD8 in tubers stored at low temperature (4°C), it was confirmed that the expression of IbFAD8 increased after 6 weeks of low temperature storage (Figure 4b).
또한, 건조 스트레스 처리를 위해 잎이 달린 엽병을 30%의 PEG (polyethylene glycol)가 담겨있는 1.5 ㎖ 튜브에 담근 후 시간별 유전자 발현을 분석하였다. 그 결과, IbFAD8의 발현은 건조 스트레스 처리에 의해 급격하게 감소되는 것으로 확인되었다(도 4c).Additionally, for drying stress treatment, leaf petioles were immersed in a 1.5 ml tube containing 30% PEG (polyethylene glycol) and then gene expression was analyzed over time. As a result, it was confirmed that the expression of IbFAD8 was drastically reduced by drying stress treatment (Figure 4c).
실시예 4. Example 4. IbFAD8IbFAD8 과발현 형질전환 고구마 제작 및 환경스트레스 내성평가 Production of overexpression transgenic sweet potatoes and evaluation of environmental stress tolerance
고구마에서 IbFAD8의 기능을 분석하기 위해, IbFAD8 과발현 벡터를 구축하여 아그로박테리움을 매개로 하여, 중국 고위도지역에서 잘 자라는 고구마 품종인 Xushu 29의 배발생 캘러스에 도입하였다(도 5a). 상기 배발생 캘러스는 고구마 식물체 마디에서 적출한 분열조직(meristem)을 Thiamine-HCl (vitamin B2), myo-inositiol (vitamin B8) 및 식물호르몬 옥신이 각각 0.4, 100 및 1 ㎎/ℓ 농도로 첨가된 MS 배지에 치상한 후 25℃의 암조건에서 3개월간 배양하여 유도한 것을 사용하였다. 항생제 조건 배지에서 분화된 고구마 식물체의 잎에서 gDNA를 추출하여 정방향 프라이머(5'-AGTGAGCGCAACGCAATTAATGTG-3', 서열번호 7) 및 역방향 프라이머(서열번호 4)를 사용하여 PCR로 형질전환 여부를 검정하였으며(도 5b), 선발된 형질전환체 중 qRT-PCR을 이용하여 잎에서 IbFAD8 유전자의 발현이 높은 5번 및 6번 라인을 선발하여 각각 TF5, TF6으로 명명한 후 다음 실험에 활용하였다(도 5c).To analyze the function of IbFAD8 in sweet potato, an IbFAD8 overexpression vector was constructed and introduced into the embryogenic callus of Xushu 29, a sweet potato variety that grows well in high latitudes in China, using Agrobacterium (Figure 5a). The embryonic callus is made by adding meristem (meristem) extracted from sweet potato plant nodes to which Thiamine-HCl (vitamin B2), myo-inositiol (vitamin B8), and plant hormone auxin are added at concentrations of 0.4, 100, and 1 mg/l, respectively. The cells were incubated in MS medium and incubated in dark conditions at 25°C for 3 months to induce induction. gDNA was extracted from the leaves of sweet potato plants differentiated in antibiotic condition medium, and transformation was tested by PCR using forward primer (5'-AGTGAGCGCAACGCAATTAATGTG-3', SEQ ID NO: 7) and reverse primer (SEQ ID NO: 4) ( Figure 5b), among the selected transformants, lines 5 and 6 with high expression of the IbFAD8 gene in leaves were selected using qRT-PCR, named TF5 and TF6, respectively, and used in the next experiment (Figure 5c) .
TF 라인 식물체를 이용하여 저온(4℃) 및 건조 스트레스 내성평가를 수행하였다. 4주 생육한 비형질전환 고구마(NT) 및 TF 라인 식물체에 저온 스트레스를 처리하고, Fv/Fm 측정, MDA 함량 측정, 엽록소 함량 분석을 통해 내성을 평가하였다. Fv/Fm 값은 광계 2에서 방출되는 엽록소 형광을 측정하는 Handy PEA fluorometer (Hansatech) 기기를 이용하여 20분간 암처리한 식물체의 3, 4번째 잎에서 방출되는 형광을 측정을 측정하여 계산하였고, MDA 함량은 생중량 50 mg의 고구마에서 0.1% trichloroacetic acid (TCA)로 추출한 추출물을 0.5% thiobarbituric acid (TBA)와 혼합한 후 약 90℃의 물에 반응시킨 후 혼합물에서 TBA-MDA 복합체의 최대 측정파장인 532 nm 및 비특이적 값 측정파장인 600 nm 흡광도를 측정하여, MDA 함량을 계산하였으며, 엽록소 함량 측정은 SPAD-502 (Konica Minolta)를 이용하여 고구마 식물체 3, 4번째 잎의 엽록소 함량을 SPAD unit으로 측정하였다. 분석 결과, TF 라인 식물체의 저온 내성이 증가되었음을 확인할 수 있었다(도 6a). 또한 수분 공급 정지를 통한 건조 스트레스 처리 결과에서도 TF 라인 식물체에서 뚜렷한 건조 스트레스 내성 증가가 확인되었다(도 6b).Low temperature (4°C) and drying stress tolerance evaluations were performed using TF line plants. Non-transgenic sweet potato (NT) and TF line plants grown for 4 weeks were treated with cold stress, and tolerance was evaluated through Fv/Fm measurement, MDA content measurement, and chlorophyll content analysis. The Fv/Fm value was calculated by measuring the fluorescence emitted from the 3rd and 4th leaves of plants dark-treated for 20 minutes using a Handy PEA fluorometer (Hansatech), which measures chlorophyll fluorescence emitted from photosystem 2, and MDA The content is determined by mixing the extract extracted with 0.1% trichloroacetic acid (TCA) from 50 mg of fresh weight sweet potato with 0.5% thiobarbituric acid (TBA) and reacting it in water at about 90°C. The maximum measured wavelength of the TBA-MDA complex in the mixture is The MDA content was calculated by measuring the absorbance at 532 nm and 600 nm, which is the non-specific measurement wavelength. The chlorophyll content was measured using SPAD-502 (Konica Minolta), and the chlorophyll content of the 3rd and 4th leaves of sweet potato plants was measured in SPAD units. Measured. As a result of the analysis, it was confirmed that the low temperature tolerance of the TF line plants was increased (Figure 6a). In addition, a clear increase in drying stress tolerance was confirmed in the TF line plants as a result of drying stress treatment through suspension of water supply (Figure 6b).
5개월 생육한 NT와 TF 라인 식물체로부터 뿌리를 수확하고, 굳은뿌리 (pencil roots, PR)와 덩이뿌리 (tuberous roots, TR)로 분류하였다. 식물체 당 뿌리발달 확인결과, NT와 TF 라인 간 뿌리무게 및 발달률에 유의한 차이가 없어 IbFAD8 유전자는 고구마 뿌리발달에 영향이 없음을 확인하였다(도 7).Roots were harvested from NT and TF line plants grown for 5 months, and classified into pencil roots (PR) and tuberous roots (TR). As a result of confirming root development per plant, there was no significant difference in root weight and development rate between NT and TF lines, confirming that the IbFAD8 gene had no effect on sweet potato root development (Figure 7).
수확된 NT와 TF 라인 식물체의 덩이뿌리를 6주간 적정 저장온도(13℃) 및 저온(4℃) 조건에서 저장하며 저온 저장성을 평가하였다. 그 결과, NT에서는 저온으로 인한 뿌리 썩음 및 무름 정도가 심하게 나타난 반면, TF 라인에서는 뿌리 단면의 피질(cortex)에 약간의 갈변증상만 나타났다(도 8a). 생화학적 분석으로 지질과산화 지표인 MDA (malondialdehyde)의 함량을 분석한 결과, 저온 조건에서 TF 라인보다 NT에서 MDA 함량이 높게 나타났다(도 8b). 상기 결과를 통해 TF 라인 식물체의 덩이뿌리의 저온 저장성이 향상되었음을 알 수 있었다. 이는 고구마의 저온 저장성을 높임으로써 고구마 수확 후 저장관리 측면의 개선 가능성을 제시하였다.The tubers of harvested NT and TF line plants were stored under appropriate storage temperature (13°C) and low temperature (4°C) conditions for 6 weeks, and low-temperature storage was evaluated. As a result, the NT showed severe root rot and softness due to low temperature, whereas the TF line showed only slight browning symptoms in the cortex of the root cross section (Figure 8a). As a result of analyzing the content of MDA (malondialdehyde), an indicator of lipid peroxidation, by biochemical analysis, the MDA content was found to be higher in the NT line than in the TF line under low temperature conditions (Figure 8b). The above results showed that the low-temperature storage properties of the tubers of the TF line plants were improved. This suggests the possibility of improving storage management after harvesting sweet potatoes by increasing the low-temperature storage of sweet potatoes.
실시예 5. 형질전환 고구마 지방산 조성 변화 분석Example 5. Analysis of changes in fatty acid composition of transgenic sweet potatoes
IbFAD8 과발현으로 인한 고구마 지방산 조성변화를 분석하기 위해, Gas chromatography (GC)를 이용하여 NT와 TF 라인 식물체의 잎 및 덩이뿌리에서 팔미트산(16:0), 스테아린산(18:0), 올레산(18:1), 리놀레산(18:2) 및 리놀렌산(18:3) 지방산의 조성(%)을 분석하였다. 지방산 조성은 불꽃 이온화 검출기(flame ionization detector)가 장착된 Agilent series 7890A (Agilent Technologies Inc.)를 활용하여 GC (gas chromatography) 분석으로 수행하였으며, 상세한 방법은 상기 실시예 2의 방법과 동일하다.To analyze changes in sweet potato fatty acid composition due to IbFAD8 overexpression, gas chromatography (GC) was used to analyze palmitic acid (16:0), stearic acid (18:0), and oleic acid ( The composition (%) of fatty acids (18:1), linoleic acid (18:2), and linolenic acid (18:3) was analyzed. Fatty acid composition was analyzed by GC (gas chromatography) using an Agilent series 7890A (Agilent Technologies Inc.) equipped with a flame ionization detector, and the detailed method was the same as that of Example 2.
그 결과, 잎에서는 NT 대비 TF 라인에서 리놀레산(18:2)의 조성이 감소되었으며, 리놀렌산(18:3)의 조성은 미미하게 증가된 것을 확인할 수 있었다(표 1). 반면, 덩이뿌리에서는 NT 대비 TF 라인에서 리놀레산(18:2)의 조성이 약 2배 정도 감소되고, 리놀렌산(18:3)의 조성은 약 4배 정도 증가하여 리놀렌산/리놀레산 비율이 NT 대비 약 8~9배로 매우 높은 수준으로 증가되었음을 확인할 수 있었다(표 2).As a result, it was confirmed that in the leaves, the composition of linoleic acid (18:2) was decreased in the TF line compared to NT, and the composition of linolenic acid (18:3) was slightly increased (Table 1). On the other hand, in tubers, the composition of linoleic acid (18:2) is reduced by about 2 times in the TF line compared to NT, and the composition of linolenic acid (18:3) is increased by about 4 times, so that the linolenic acid/linoleic acid ratio is about 8 compared to NT. It was confirmed that it had increased to a very high level of ~9-fold (Table 2).
상기 결과를 통해 IbFAD8 유전자를 이용하여 고혈압, 심혈관질환 등에 효과가 있다고 알려진 식물 유래 오메가-3 리놀렌산 고함량 고구마를 개발할 수 있는 가능성을 확인하였다.The above results confirmed the possibility of developing sweet potatoes high in plant-derived omega-3 linolenic acid, which are known to be effective in high blood pressure and cardiovascular diseases, using the IbFAD8 gene.
<110> Korea Research Institute of Bioscience and Biotechnology <120> IbFAD8 gene from sweetpotato for improving cold storage stability and increasing omega-3 fatty acid content in tuberous root of sweetpotato and uses thereof <130> PN21044 <160> 7 <170> KoPatentIn 3.0 <210> 1 <211> 1338 <212> DNA <213> Ipomoea batatas <400> 1 atggcgagtt gggtgttatc agaatgtggt ctcagaccat tccccaaaat ctaccctaag 60 ccaagaactg ggatgggttc tctcagttgt ggcagcccct caaggctgac agttgcaggg 120 acagatctgg ggtcttgttc tttgattggg attagggaga ggaattgggc attgagggtt 180 agtgccccag tgagggttcc ctcagttggg gaggaagagg aagaagagag ggagagtatc 240 aatgttgtca atggggatgg ggatgagttt tttgaccctg gggcaccacc cccatttaag 300 ctgtctgata ttagagcagc cattcctaag cattgctggg ttaaggaccc ttggaagtcc 360 atgagctttg tggttaggga tgttgcaatt gtgtttggat tggcagctgt ggctgcttct 420 ctcaataatt ggattgtttg gcctctgtat tggttggctc aaggaaccat gttctgggct 480 ctctttgttc ttggccatga ctgtggccat ggaagctttt ctaatgaccc aaagctgaac 540 agtgttgctg gccatctcct ccactcttca attcttgtcc cttaccatgg atggagaatt 600 agccatagga ctcatcacca gaaccatggc catgtcgaaa atgatgaatc ttggcaccct 660 ctgcctgaga agatattcaa gagccttgac aatgtcacga gaaagttgag gttcaccata 720 ccgttcccac tgcttgcata ccccgtctat ctgtggagta gaagccctgg gaagaaaggc 780 tctcattttg atccaaacag cgatttgttt gtgccaaatg agaagaaaga cgtgattacc 840 tcaaccgtgt gttggtcagc catggttgct atccttgctg gtttatcgtt cgtgatgggg 900 cccgtccaat tgctcaaact ctatggagtt ccatatgcga tctttgttat gtggctggat 960 ttagtcacct acttacatca tcatggacat gaagacaaac ttccatggta tcgtggaaag 1020 gaatggagtt accttagggg tggactgacc actcttgatc gcgactatgg atggataaac 1080 aacatacacc acgatattgg gacccatgtc atacatcatc ttttccccca aatccctcat 1140 tatcacttga tcgaagctac cgaggctgct aagccagtgc tcgggaagta ttacagagag 1200 ccgaagaaat catggcctct tccattgcac ctgttgggag acctcgtgag aagcatgaag 1260 aaggatcact acgtgagtga tgacggggat gttgtatatt accaaaccga ccccaagctt 1320 gctggaaccg agaagtga 1338 <210> 2 <211> 445 <212> PRT <213> Ipomoea batatas <400> 2 Met Ala Ser Trp Val Leu Ser Glu Cys Gly Leu Arg Pro Phe Pro Lys 1 5 10 15 Ile Tyr Pro Lys Pro Arg Thr Gly Met Gly Ser Leu Ser Cys Gly Ser 20 25 30 Pro Ser Arg Leu Thr Val Ala Gly Thr Asp Leu Gly Ser Cys Ser Leu 35 40 45 Ile Gly Ile Arg Glu Arg Asn Trp Ala Leu Arg Val Ser Ala Pro Val 50 55 60 Arg Val Pro Ser Val Gly Glu Glu Glu Glu Glu Glu Arg Glu Ser Ile 65 70 75 80 Asn Val Val Asn Gly Asp Gly Asp Glu Phe Phe Asp Pro Gly Ala Pro 85 90 95 Pro Pro Phe Lys Leu Ser Asp Ile Arg Ala Ala Ile Pro Lys His Cys 100 105 110 Trp Val Lys Asp Pro Trp Lys Ser Met Ser Phe Val Val Arg Asp Val 115 120 125 Ala Ile Val Phe Gly Leu Ala Ala Val Ala Ala Ser Leu Asn Asn Trp 130 135 140 Ile Val Trp Pro Leu Tyr Trp Leu Ala Gln Gly Thr Met Phe Trp Ala 145 150 155 160 Leu Phe Val Leu Gly His Asp Cys Gly His Gly Ser Phe Ser Asn Asp 165 170 175 Pro Lys Leu Asn Ser Val Ala Gly His Leu Leu His Ser Ser Ile Leu 180 185 190 Val Pro Tyr His Gly Trp Arg Ile Ser His Arg Thr His His Gln Asn 195 200 205 His Gly His Val Glu Asn Asp Glu Ser Trp His Pro Leu Pro Glu Lys 210 215 220 Ile Phe Lys Ser Leu Asp Asn Val Thr Arg Lys Leu Arg Phe Thr Ile 225 230 235 240 Pro Phe Pro Leu Leu Ala Tyr Pro Val Tyr Leu Trp Ser Arg Ser Pro 245 250 255 Gly Lys Lys Gly Ser His Phe Asp Pro Asn Ser Asp Leu Phe Val Pro 260 265 270 Asn Glu Lys Lys Asp Val Ile Thr Ser Thr Val Cys Trp Ser Ala Met 275 280 285 Val Ala Ile Leu Ala Gly Leu Ser Phe Val Met Gly Pro Val Gln Leu 290 295 300 Leu Lys Leu Tyr Gly Val Pro Tyr Ala Ile Phe Val Met Trp Leu Asp 305 310 315 320 Leu Val Thr Tyr Leu His His His Gly His Glu Asp Lys Leu Pro Trp 325 330 335 Tyr Arg Gly Lys Glu Trp Ser Tyr Leu Arg Gly Gly Leu Thr Thr Leu 340 345 350 Asp Arg Asp Tyr Gly Trp Ile Asn Asn Ile His His Asp Ile Gly Thr 355 360 365 His Val Ile His His Leu Phe Pro Gln Ile Pro His Tyr His Leu Ile 370 375 380 Glu Ala Thr Glu Ala Ala Lys Pro Val Leu Gly Lys Tyr Tyr Arg Glu 385 390 395 400 Pro Lys Lys Ser Trp Pro Leu Pro Leu His Leu Leu Gly Asp Leu Val 405 410 415 Arg Ser Met Lys Lys Asp His Tyr Val Ser Asp Asp Gly Asp Val Val 420 425 430 Tyr Tyr Gln Thr Asp Pro Lys Leu Ala Gly Thr Glu Lys 435 440 445 <210> 3 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 atggcgagtt gggtgttatc 20 <210> 4 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 tcacttctcg gttccagcaa 20 <210> 5 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 cccccattta agctgtctga 20 <210> 6 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 acatggttcc ttgagccaac 20 <210> 7 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 7 agtgagcgca acgcaattaa tgtg 24 <110> Korea Research Institute of Bioscience and Biotechnology <120> IbFAD8 gene from sweetpotato for improving cold storage stability and increasing omega-3 fatty acid content in tuberous root of sweetpotato and uses it <130>PN21044 <160> 7 <170> KoPatentIn 3.0 <210> 1 <211> 1338 <212> DNA <213> Ipomoea batatas <400> 1 atggcgagtt gggtgttatc agaatgtggt ctcagaccat tccccaaaat ctaccctaag 60 ccaagaactg ggatgggttc tctcagttgt ggcagcccct caaggctgac agttgcaggg 120 acagatctgg ggtcttgttc tttgatggg attagggaga ggaattgggc attgagggtt 180 agtgccccag tgagggttcc ctcagttggg gaggaagagg aagaagagag ggagagtatc 240 aatgttgtca atggggatgg ggatgagttt tttgaccctg gggcaccacc cccatttaag 300 ctgtctgata ttagagcagc cattcctaag cattgctggg ttaaggaccc ttggaagtcc 360 atgagctttg tggttaggga tgttgcaatt gtgtttggat tggcagctgt ggctgcttct 420 ctcaataatt ggattgtttg gcctctgtat tggttggctc aaggaaccat gttctgggct 480 ctctttgttc ttggccatga ctgtggccat ggaagctttt ctaatgaccc aaagctgaac 540 agtgttgctg gccatctcct ccactcttca attcttgtcc cttaccatgg atggagaatt 600 agccatagga ctcatcacca gaaccatggc catgtcgaaa atgatgaatc ttggcaccct 660 ctgcctgaga agatattcaa gagccttgac aatgtcacga gaaagttgag gttcaccata 720 ccgttcccac tgcttgcata ccccgtctat ctgtggagta gaagccctgg gaagaaaggc 780 tctcattttg atccaaacag cgatttgttt gtgccaaatg agaagaaaga cgtgattacc 840 tcaaccgtgt gttggtcagc catggttgct atccttgctg gtttatcgtt cgtgatgggg 900 cccgtccaat tgctcaaact ctatggagtt ccatatgcga tctttgttat gtggctggat 960 ttagtcacct acttacatca tcatggacat gaagacaaac ttccatggta tcgtggaaag 1020 gaatggagtt accttagggg tggactgacc actcttgatc gcgactatgg atggataaac 1080 aacatacacc acgatattgg gacccatgtc atacatcatc ttttccccca aatccctcat 1140 tatcacttga tcgaagctac cgaggctgct aagccagtgc tcgggaagta ttacagagag 1200 ccgaagaaat catggcctct tccattgcac ctgttgggag acctcgtgag aagcatgaag 1260 aaggatcact acgtgagtga tgacggggat gttgtatatt accaaaccga ccccaagctt 1320 gctggaaccg agaagtga 1338 <210> 2 <211> 445 <212> PRT <213> Ipomoea batatas <400> 2 Met Ala Ser Trp Val Leu Ser Glu Cys Gly Leu Arg Pro Phe Pro Lys 1 5 10 15 Ile Tyr Pro Lys Pro Arg Thr Gly Met Gly Ser Leu Ser Cys Gly Ser 20 25 30 Pro Ser Arg Leu Thr Val Ala Gly Thr Asp Leu Gly Ser Cys Ser Leu 35 40 45 Ile Gly Ile Arg Glu Arg Asn Trp Ala Leu Arg Val Ser Ala Pro Val 50 55 60 Arg Val Pro Ser Val Gly Glu Glu Glu Glu Glu Glu Arg Glu Ser Ile 65 70 75 80 Asn Val Val Asn Gly Asp Gly Asp Glu Phe Phe Asp Pro Gly Ala Pro 85 90 95 Pro Pro Phe Lys Leu Ser Asp Ile Arg Ala Ala Ile Pro Lys His Cys 100 105 110 Trp Val Lys Asp Pro Trp Lys Ser Met Ser Phe Val Val Arg Asp Val 115 120 125 Ala Ile Val Phe Gly Leu Ala Ala Val Ala Ala Ser Leu Asn Asn Trp 130 135 140 Ile Val Trp Pro Leu Tyr Trp Leu Ala Gln Gly Thr Met Phe Trp Ala 145 150 155 160 Leu Phe Val Leu Gly His Asp Cys Gly His Gly Ser Phe Ser Asn Asp 165 170 175 Pro Lys Leu Asn Ser Val Ala Gly His Leu Leu His Ser Ser Ile Leu 180 185 190 Val Pro Tyr His Gly Trp Arg Ile Ser His Arg Thr His His Gln Asn 195 200 205 His Gly His Val Glu Asn Asp Glu Ser Trp His Pro Leu Pro Glu Lys 210 215 220 Ile Phe Lys Ser Leu Asp Asn Val Thr Arg Lys Leu Arg Phe Thr Ile 225 230 235 240 Pro Phe Pro Leu Leu Ala Tyr Pro Val Tyr Leu Trp Ser Arg Ser Pro 245 250 255 Gly Lys Lys Gly Ser His Phe Asp Pro Asn Ser Asp Leu Phe Val Pro 260 265 270 Asn Glu Lys Lys Asp Val Ile Thr Ser Thr Val Cys Trp Ser Ala Met 275 280 285 Val Ala Ile Leu Ala Gly Leu Ser Phe Val Met Gly Pro Val Gln Leu 290 295 300 Leu Lys Leu Tyr Gly Val Pro Tyr Ala Ile Phe Val Met Trp Leu Asp 305 310 315 320 Leu Val Thr Tyr Leu His His His Gly His Glu Asp Lys Leu Pro Trp 325 330 335 Tyr Arg Gly Lys Glu Trp Ser Tyr Leu Arg Gly Gly Leu Thr Thr Leu 340 345 350 Asp Arg Asp Tyr Gly Trp Ile Asn Asn Ile His His Asp Ile Gly Thr 355 360 365 His Val Ile His His Leu Phe Pro Gln Ile Pro His Tyr His Leu Ile 370 375 380 Glu Ala Thr Glu Ala Ala Lys Pro Val Leu Gly Lys Tyr Tyr Arg Glu 385 390 395 400 Pro Lys Lys Ser Trp Pro Leu Pro Leu His Leu Leu Gly Asp Leu Val 405 410 415 Arg Ser Met Lys Lys Asp His Tyr Val Ser Asp Asp Gly Asp Val Val 420 425 430 Tyr Tyr Gln Thr Asp Pro Lys Leu Ala Gly Thr Glu Lys 435 440 445 <210> 3 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 atggcgagtt gggtgttatc 20 <210> 4 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 tcacttctcg gttccagcaa 20 <210> 5 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 cccccattta agctgtctga 20 <210> 6 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 acatggttcc ttgagccaac 20 <210> 7 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 7 agtgagcgca acgcaattaa tgtg 24
Claims (7)
상기 형질전환된 고구마 식물세포로부터 형질전환 고구마 식물체를 재분화하는 단계를 포함하는 야생형에 비해 덩이뿌리의 저온 저장성 및 리놀렌산(linolenic acid)의 함량이 증가된 형질전환 고구마 식물체의 제조방법.Transforming sweet potato plant cells with a recombinant vector containing a gene encoding the sweet potato IbFAD8 ( Ipomoea batatas Fatty acid desaturase 8) protein consisting of the amino acid sequence of SEQ ID NO: 2, thereby overexpressing the IbFAD8 gene; and
A method for producing a transgenic sweet potato plant with increased low-temperature storability and linolenic acid content of the tubers compared to the wild type, comprising the step of redifferentiating the transformed sweet potato plant from the transformed sweet potato plant cell.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210054406A KR102675413B1 (en) | 2021-04-27 | 2021-04-27 | IbFAD8 gene from sweetpotato for improving cold storage stability and increasing omega-3 fatty acid content in tuberous root of sweetpotato and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210054406A KR102675413B1 (en) | 2021-04-27 | 2021-04-27 | IbFAD8 gene from sweetpotato for improving cold storage stability and increasing omega-3 fatty acid content in tuberous root of sweetpotato and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220147361A KR20220147361A (en) | 2022-11-03 |
KR102675413B1 true KR102675413B1 (en) | 2024-06-13 |
Family
ID=84040653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210054406A Active KR102675413B1 (en) | 2021-04-27 | 2021-04-27 | IbFAD8 gene from sweetpotato for improving cold storage stability and increasing omega-3 fatty acid content in tuberous root of sweetpotato and uses thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102675413B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240065976A (en) | 2022-11-07 | 2024-05-14 | 엘지디스플레이 주식회사 | Touch display device and touch sensing method |
-
2021
- 2021-04-27 KR KR1020210054406A patent/KR102675413B1/en active Active
Non-Patent Citations (3)
Title |
---|
Chang Yoon Ji 외 6명, Transcriptome profiling of sweetpotato tuberous roots during low temperature storage, Plant Physiology and Biochemistry, 112, 2017년 개시, pp. 97-108* |
Meng Zhang 외 7명, Modulated fad via overexpression of two distinct w-3 desaturases alters tolerance to various abiotic stresses in transgenic tobacco, The Plant Journal, 2005년 개시, 44, pp.361-371* |
NCBI Reference Sequence, omega-3 fatty acid desaturase, chloroplastic-like [Ipomoea triloba], ACCESSION no. XP_031108882, 2019년 개시* |
Also Published As
Publication number | Publication date |
---|---|
KR20220147361A (en) | 2022-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107858204B (en) | Enzymes and methods for producing omega-3 fatty acids | |
CA2755027C (en) | Use of a seed specific promoter to drive odp1 expression in cruciferous oilseed plants to increase oil content while maintaining normal germination | |
US20180030463A1 (en) | Certain plants with "no saturate" or reduced saturate levels of fatty acids in seeds, and oil derived from the seeds | |
JP2009207421A (en) | Gene effecting increased production of plant's fat-and-oil, and method for using the gene | |
CN103403169A (en) | Materials and method for modifying a biochemical component in a plant | |
Ding et al. | AgZDS, a gene encoding ζ-carotene desaturase, increases lutein and β-carotene contents in transgenic Arabidopsis and celery | |
PT1589807E (en) | Transgenic pineapple plants with modified carotenoid levels and methods of their production | |
KR102675413B1 (en) | IbFAD8 gene from sweetpotato for improving cold storage stability and increasing omega-3 fatty acid content in tuberous root of sweetpotato and uses thereof | |
CN108085333A (en) | A kind of method that potato plant physiology is delayed to go bad | |
US9115338B2 (en) | Enhancement of beta-carotene content in plants | |
KR101987663B1 (en) | Method for reducing ethylene production by LeMADS-RIN gene editing using CRISPR/Cas9 system in plant | |
KR101164923B1 (en) | Delta-6 desaturase gene from Sparus aurata and uses thereof | |
EP1608759A2 (en) | Enhanced accumulation of carotenoids in plants | |
KR20210067151A (en) | Method for increasing color, Aroma and root development in plant | |
KR101424154B1 (en) | CvFatB1 gene and their uses in palmitic acid biosynthesis | |
KR102369344B1 (en) | Composition for modifying the ratio of unsaturated fatty acids in seeds and seeds prepared by the same | |
KR101515152B1 (en) | Method for producing transgenic plants with enhanced tolerance to environmental stress using LCY-beta gene and plants therefrom | |
US20230235347A1 (en) | Improved Camelina Plants and Plant Oil, and Uses Thereof | |
KR102110870B1 (en) | IbOr-R96H mutant from Ipomoea batatas and uses thereof | |
DE69723383T2 (en) | Gene coding for plant indole acetaldehyde oxidase and its use | |
CN118019852A (en) | Engineering modulators for increasing vegetable oil yield | |
KR20230044750A (en) | BrMYBR1 gene for the inhibition of anthocyanin biosynthesis and uses thereof | |
WO2023055291A2 (en) | Engineered regulator for improved plant oil yield | |
CN115819533A (en) | Capsanthin synthesis related transcription factor and application thereof | |
WO2002103021A2 (en) | Method for increasing the carotenoid-content in transgenic plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20210427 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20231017 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20240611 |
|
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20240611 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20240611 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |